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ABSTRACT 1 
Developmental cell fate specification is a unidirectional process that can be reverted in response to 2 
injury or experimental reprogramming. Whether differentiation and de-differentiation trajectories 3 
intersect mechanistically is unclear. Here, we performed comparative screening in lineage-related 4 
mouse naïve embryonic stem cells (ESCs) and primed epiblast stem cells (EpiSCs), and identified the 5 
constitutively expressed zinc finger transcription factor (TF) Zfp281 as a bi-directional regulator of cell 6 
state interconversion. We showed that subtle chromatin binding changes in differentiated cells translate 7 
into activation of the histone H3 lysine 9 (H3K9) methyltransferase Ehmt1 and stabilization of the zinc 8 
finger TF Zic2 at enhancers and promoters. Genetic gain- and loss-of-function experiments confirmed 9 
a critical role of Ehmt1 and Zic2 downstream of Zfp281 both in driving exit from the ESC state, and in 10 
restricting reprogramming of EpiSCs. Our study reveals that cell type-invariant chromatin association 11 




Mammalian development is a hierarchical process that coordinates organismal growth with increasing 16 
cellular differentiation. The lineage progression of the few pluripotent cells in the blastocyst towards the 17 
many specialized cell types in the mature embryo is by and large unidirectional. However, fully 18 
differentiated cells can be de-differentiated into induced pluripotent stem cells (iPSCs) by ectopic 19 
expression of the transcription factors (TFs) Oct4, Sox2, Klf4 and c-Myc (Takahashi & Yamanaka, 20 
2006). Reprogramming of somatic cells into iPSCs requires erasure of the entire developmental history 21 
of a somatic cell, but whether this depends on the reversal of developmental hierarchies is unclear 22 
(Ladewig et al, 2013; Takahashi & Yamanaka, 2015). 23 
Transcriptional and epigenomic profiling of the reprogramming process has revealed an ordered series 24 
of events that include the transient and sequential activation of late and early developmental genes 25 
(Cacchiarelli et al, 2015; Amlani et al, 2018; Takahashi et al, 2014). Although the specific trajectory is 26 
dictated by the identity of the starting somatic cell type (Nefzger et al, 2017; Jackson et al, 2016) and 27 
the experimental regime (Chantzoura et al, 2015; Stuart et al, 2019), iPSC formation may involve the 28 
reversion of natural developmental mechanisms (Takahashi & Yamanaka, 2015). Consistent with this 29 
possibility, a mesenchymal-to-epithelial transition is necessary for iPSC formation (Samavarchi-Tehrani 30 
et al, 2010; Li et al, 2010), while the converse epithelial-to-mesenchymal transition is crucial for 31 
embryogenesis, e.g. during gastrulation and neural crest formation (Acloque et al, 2009). Although it is 32 
debated if these observations reflect a shared developmental intermediate (Raab et al, 2017),  they 33 
suggest that de-differentiation and differentiation employ common mechanisms in opposite directions. 34 
Here, we systematically and functionally examine this concept using naïve pluripotent embryonic stem 35 
cells (ESCs) and primed pluripotent epiblast stem cells (EpiSCs) (Smith, 2017). 36 
ESCs and EpiSCs are developmentally related derivatives of mouse embryonic day (E) 3.75-4.5 37 
blastocysts (Boroviak et al, 2014) and E5.5-8.0 embryos (Tesar et al, 2007; Brons et al, 2007; Osorno 38 
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et al, 2012), respectively. ESCs cultured in the presence of two inhibitors (2i) resemble naïve pluripotent 1 
cells of the pre-implantation epiblast (Boroviak et al, 2014), while primed pluripotent EpiSCs cultured in 2 
the presence of FGF2 and Activin A (FA) resemble cells of the late gastrula (Osorno et al, 2012; 3 
Tsakiridis et al, 2014; Kojima et al, 2014). Upon in vitro differentiation, ESCs progress through a 4 
transient post-implantation epiblast-like (EpiLC) cell state that is amenable to EpiSC derivation (Zhang 5 
et al, 2010; Hayashi et al, 2011). Conversely, activation of just one TF, such as Stat3, Klf4, or Esrrb, is 6 
sufficient to reprogram EpiSCs into naïve pluripotent EpiSC-derived iPSCs (Epi-iPSCs) in the presence 7 
of 2i (Yang et al, 2010; Guo et al, 2009; Festuccia et al, 2012). The interconvertibility of ESCs and 8 
EpiSCs thus provides an experimental system to explore if de-differentiation includes the reversion of 9 
differentiation mechanisms. 10 
Using a large-scale loss-of-function reprogramming screen in sensitized EpiSCs we identify the zinc 11 
finger TF Zfp281 as a prominent bidirectional ESC-EpiSC transition regulator. We show that Zfp281 12 
exhibits stable chromatin association and drives ESC progression through differentiation-specific 13 
interaction with Ehmt1 and Zic2. Genomic analysis revealed activation of Ehmt1 and enrichment of Zic2 14 
at Zfp281-bound cis-regulatory elements (CREs) that are associated with developmental transcription 15 
in EpiLCs and EpiSCs. Zfp281, therefore, establishes and stabilizes cell fate commitment to safeguard 16 
the unidirectionality of pluripotent state transitions. 17 
 18 
RESULTS 19 
Zfp281 is a bidirectional ESC-EpiSC transition regulator 20 
We hypothesized that mechanisms common to differentiation and de-differentiation may be encoded in 21 
genes that both promote exit from the naïve ESC state and impair reprogramming of EpiSCs. ESC 22 
differentiation drivers have been determined in several genetic loss of function screens (Betschinger et 23 
al, 2013; Li et al, 2018; Leeb et al, 2014; Guo et al, 2011; Westerman et al, 2011), but it is unknown if 24 
those also inhibit reprogramming of EpiSCs into naïve pluripotency. We therefore set out to 25 
systematically identify reprogramming roadblocks using a large-scale endoribonuclease-prepared small 26 
interfering RNA (esiRNA) loss-of-function screen (Ding et al, 2009). We made use of O4GIPGY118F 27 
EpiSCs expressing green fluorescent protein (GFP) and Puromycin N-acetyl-transferase under the 28 
regulatory sequences of the Oct4 gene (Guo et al, 2009), and a Stat3 activating receptor (GY118F) 29 
responsive to granulocyte colony stimulating factor (Gcsf) driven by a constitutive promoter (Yang et al, 30 
2010). Upon exposure to Gcsf and 2i for 4 days (d), O4GIPGY118F EpiSCs gave rise to self-renewing 31 
Epi-iPSCs at an efficiency of roughly 0.1% (Figure EV1A), thus providing a sensitized setup to identify 32 
reprogramming inhibitors. O4GIPGY118F EpiSCs were transfected with esiRNAs targeting 9540 33 
transcripts and control esiRNAs targeting Luciferase (Luc) and the GY118F downstream effector Stat3 34 
in 384 well plates (Figure 1A). The next day, reprogramming was induced by changing to 2i and Gcsf. 35 
After 4d, we selected Epi-iPSCs in the presence of Puromycin, and quantified viability with a fluorescent 36 
assay after 3-4d. The screen was performed in duplicate and Z scores were calculated per plate (Table 37 
EV1). Positive (Stat3 esiRNA), but not negative (non-targeting Luc esiRNA and no esiRNA) controls 38 
induced negative Z scores (Figure EV1B). Screen hits with average Z scores < -2 included ribosome 39 
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and proteasome subunits, Stat3 and Oct4 (Figure 1B), and were strongly enriched for functions 1 
associated with RNA maturation and translation using gene ontology (GO) analysis (Figure EV1C). 2 
These therefore contain genes required for reprogramming and/or cell survival. Screen hits with positive 3 
Z scores, conversely, are expected to inhibit reprogramming and/or proliferation. Among the 146 hits 4 
with an average Z score > 2, the zinc finger TF Zfp281 and the E3 ubiquitin ligase Fbxw7 scored highest. 5 
Zfp281 and Fbxw7 have previously been shown to restrict iPSC generation from somatic cells (Fidalgo 6 
et al, 2012; Buckley et al, 2012; Okita et al, 2012; Fidalgo et al, 2016), thus suggesting successful 7 
identification of reprogramming roadblocks. 8 
To determine if any of the 146 genes also drive ESC differentiation, we compared our screen hits with 9 
those from two previous large-scale ESC differentiation loss-of-function studies (Betschinger et al, 10 
2013; Li et al, 2018) (Figure 1C). Zfp281 and the cytochrome c oxidase subunits Cox5a and Cox6c 11 
scored strongest in all screens. For validation, we depleted each of them by siRNA transfection in 12 
independent GY118F-expressing Oct4 reporter 796.4 EpiSCs (Yang et al, 2010) and also included 13 
siRNAs targeting Fbxw7 and Tcf7l1 as controls (Figure 1B, C). Knockdown of Fbxw7 and Zfp281, but 14 
not of Cox5a, Cox6c or Tcf7l1 increased reprogramming (Figure 1D, EV1D). Therefore, Cox5a and 15 
Cox6c are false-positive or cell line-dependent screen hits, and we focused our further efforts on 16 
Zfp281. Consistent with previous findings (Fidalgo et al, 2016), Epi-iPSCs derived by Zfp281 depletion 17 
expressed the naïve TFs Esrrb, Klf4, Nr0b1 and Tbx3, and reduced levels of the primed markers Oct6, 18 
Fgf5, Sox3 and Dnmt3b (Figure EV1E), suggesting successful reversion to the pluripotent ground state. 19 
To quantify the dynamics of this process, we used self-renewal in 2i as a proxy for acquisition of Epi-20 
iPSC identity. Compared to controls, Zfp281 depletion dramatically increased the colony forming 21 
capacity of single cells after 2d and 4d of Gcsf addition (Figure 1E), indicating accelerated and more 22 
efficient reprogramming of EpiSCs. Gcsf supplementation was essential and co-depletion of Stat3 23 
abolished Epi-iPSC formation from O4GIPGY118F EpiSCs in the presence of Gcsf (Figure EV1F). 24 
Similarly, Leukemia inhibitory factor (Lif), which activates Stat3 in EpiSCs (Yang et al, 2010), was 25 
required for reprogramming of Zfp281-depleted OEC2 EpiSCs (Figure 1F). To test if Zfp281 acts only 26 
in the context of active Stat3, we used conditional expression of Esrrb or Klf4 in O4GIP EpiSCs through 27 
addition of Doxycycline (Dox) to induce reprogramming. In the absence of extrinsic Lif we observed an 28 
increase in Dox-induced Epi-iPSC colonies upon knockdown of Zfp281 (Figure 1G), suggesting that 29 
Zfp281 functions independent of the specific reprogramming regime. Taken together these findings 30 
demonstrate that the vast majority of cell state transition regulators act unidirectionally. Zfp281, in 31 
contrast, acts bidirectionally as it drives ESC differentiation and inhibits reprogramming of EpiSCs. 32 
Notably, this is inverse to the activity of reprogramming TFs, e.g. Klf4 and Esrrb, that induce and 33 
consolidate the naïve ESC state (Yamane et al, 2018; Festuccia et al, 2012; Guo et al, 2009; Martello 34 
et al, 2012; Niwa et al, 2009). 35 
Zfp281 promotes exit from naïve pluripotency independent of Tet1 and Tet2 36 
To characterize the function of Zfp281 in ESC differentiation, we inactivated the gene in naïve RGd2 37 
ESCs that contain a destabilized GFP protein downstream of the Rex1 (Zfp42) promoter (Figure EV2A, 38 
B) which allows near real-time tracking of cell state transition (Kalkan et al, 2017): GFP is 39 
 5 
homogeneously expressed in 2i and up to 16 hours (h) after 2i withdrawal (GFPhigh)  (Kalkan et al, 2017) 1 
before becoming progressively downregulated (GFPlow) as ESCs exit from self-renewal (Figure EV2C). 2 
In 2i, reporter expression in two independent Zfp281 knockout (KO) clones was similar to the parental 3 
wildtype cell line (WT) and an untargeted wildtype sibling clone (Zfp281 WT) (Figure EV2D). In contrast, 4 
32h and 72h after 2i withdrawal, 30% and less than 1% of WT cells were GFPhigh, while 75% and 10% 5 
of Zfp281 KO cells maintained high GFP expression, respectively. Consistent with impaired exit from 6 
the ESC state, 10% of Zfp281 KO cells formed colonies in 2i after 72h of differentiation (Figure 2A). 7 
This phenotype was reverted by transgenic Zfp281 expression (Figure 2B). Resistance to exit self-8 
renewal was also observed in KO cells generated in a different ESC line (Figure EV2A, B, E), and in 9 
EpiLC (Hayashi et al, 2011) and embryoid body (EB) differentiation regimes (Figure 2A, EV2D). Zfp281 10 
mutant cells maintained Rex1 reporter expression and self-renewal even after lengthy periods in the 11 
absence of 2i (Figure 2A, EV2D), demonstrating that differentiation resistance is persistent.  12 
Differentiating Zfp281 KO cells expressed varied levels of the Rex1 reporter (Figure EV2D) and formed 13 
colonies in 2i less efficiently than naïve pluripotent ESCs. E.g. 32h after 2i withdrawal, mutant cells 14 
displayed only 40% of the self-renewal capacity of ESCs (Figure EV1F). To test if this reduction is linked 15 
to population heterogeneity, we purified GFPhigh and GFPlow cells at 32h using fluorescence-activated 16 
cell sorting. As expected (Kalkan et al, 2017), sorted WT GFPlow cells were largely committed to 17 
differentiation and unable to generate clones in 2i (Figure 2C). In contrast, Zfp281 KO GFPlow cells 18 
formed colonies almost as efficiently as GFPhigh cells. Rex1 downregulation and exit from the ESC state 19 
is, thus, disconnected in Zfp281 mutants. However, the efficiency with which GFPhigh cells formed 20 
colonies after 32h of 2i withdrawal was lower than of GFPhigh cells after 24h (Kalkan et al, 2017) and of 21 
ESCs (Figure 2C). This was irrespective of genotype, suggesting a gradual decline of self-renewal 22 
during differentiation both in Zfp281 mutant and WT GFPhigh cells. The reduced clonogenicity of Zfp281 23 
KO populations compared to ESCs may therefore be consequential to impaired progression of an 24 
advanced cell state with limited self-renewal capacity and independent of population heterogeneity. In 25 
fact, GFPlow cells in long-term differentiated Zfp281 mutants re-established GFPhigh expression within a 26 
few days (Figure EV2G), revealing reversibility of the GFPlow state in the absence of Zfp281. To test 27 
sufficiency, we generated naïve RGd2 cells conditionally overexpressing Zfp281 under Dox regulation 28 
(Figure EV2H). Dox-treatment in the presence of 2i induced silencing of the Rex1 reporter and loss of 29 
self-renewal in a subset of cells (Figure 2D, EV2I). Zfp281 is therefore required and sufficient for exit 30 
from naïve pluripotency. 31 
A previous study showed that differentiation of Serum/Lif-cultured ESCs is accompanied by up-32 
regulation of Zfp281, which in turn destabilizes metastable pluripotency by binding to the methylcytosine 33 
hydroxylase Tet1 and transcriptionally suppressing Tet2 (Fidalgo et al, 2016). If the same mechanisms 34 
were to regulate exit from naïve pluripotency downstream of Zfp281, loss of Tet1 should induce the 35 
same phenotype as loss of Zfp281, and loss of Tet2 the opposite. We therefore generated Tet1, Tet2 36 
and Zfp281/Tet2 KO alleles in naïve RGd2 ESCs (Figure EV2J, K). Strikingly, the extinction of the Rex1 37 
reporter and self-renewal was similar in differentiating WT cells and Tet1 and Tet2 mutants, while 38 
absence of Tet2 in Zfp281/Tet2 KO cells did not revert resistance to differentiation caused by absence 39 
of Zfp281 alone (Figure 2E, EV2L). We furthermore noted only modest changes in Zfp281 mRNA or 40 
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protein during ESC differentiation, and across existing RNA sequencing (RNA-seq) datasets of EpiLC 1 
and EpiSC differentiation (Buecker et al, 2014; Factor et al, 2014; Bao et al, 2018) and epiblast 2 
development (Boroviak et al, 2015) (Figure 2F, EV2M). Zfp281 has also been reported to repress Nanog 3 
transcription through interacting with the NuRD complex in Serum/Lif-cultured ESCs (Fidalgo et al, 4 
2012). However, Nanog mRNA was unchanged in naïve Zfp281 KO ESCs or EpiSCs depleted of 5 
Zfp281 by siRNA transfection (Figure EV2N, O). Furthermore, knockdown of Nanog did not restore 6 
differentiation in ESCs depleted of Zfp281 while it partially did so, as expected (Pereira et al, 2006), in 7 
ESCs depleted of Tcf7l1 (Figure EV2P). Taken together these results suggest that Zfp281 is expressed 8 
fairly constantly during exit from naïve pluripotency and drives differentiation independent of Tet1, Tet2 9 
and Nanog. 10 
Zfp281 acts independent of cell state-exclusive chromatin association 11 
To identify the transcriptional defects causing differentiation resistance, we performed RNA-seq of WT 12 
and Zfp281 KO cells in 2i, and 16h and 32h after 2i withdrawal (WT2i,16h,32h and Zfp2812i,16h,32h) (Table 13 
EV2). The expression of several naïve and primed pluripotency markers was perturbed in Zfp28116h 14 
and Zfp28132h cells (Figure EV3A), confirming impaired silencing of naïve identity in Zfp281 mutants. 15 
k-means clustering of mRNAs that significantly changed during WT differentiation or in Zfp281 KO cells 16 
(2495 genes) identified six gene clusters (Figure 3A, B): Clusters 1-4 (1898 genes) contain the majority 17 
of genes that were differentially transcribed in WT32h cells and of which a subset was already regulated 18 
in WT16h cells. Comparison with external EpiLC (Buecker et al, 2014) and EpiSC (Factor et al, 2014; 19 
Bao et al, 2018) expression datasets, which were not employed in the clustering analysis, revealed 20 
persistence of the bulk transcriptional changes established in WT32h cells, suggesting that clusters 1-4 21 
contribute to pluripotent cell state progression. Clusters 5 and 6 (597 genes), in contrast, contain genes 22 
that were mostly unchanged in WT32h cells, but transiently regulated in WT16h cells and differentially 23 
expressed in EpiSCs. Clusters 5 and 6 may therefore act in gastrulation stage epiblast development 24 
and/or EpiSCs. 25 
Clusters 1 and 2 were largely unaffected in differentiating Zfp281 KO cells, whereas the repression and 26 
induction, respectively, of cluster 3 and 4 genes was blunted in both Zfp28116h and Zfp28132h cells 27 
(Figure 3A, B). Cell state-specific comparison revealed that this was predominantly due to deregulation 28 
during differentiation (Figure 3C). Although we can’t exclude that the transcriptional defects in Zfp28132h 29 
cells were influenced by cell state heterogeneity (Figure EV2D), perturbed expression of cluster 3 and 30 
4 genes in Zfp28116h cells, a timepoint at which downregulation of Rex1 reporter expression (Kalkan et 31 
al, 2017) and exit from self-renewal (Figure EV2C, F) has not yet commenced, suggests a direct role 32 
of Zfp281 in regulating these genes. Zfp281 may therefore drive exit from naïve pluripotency through 33 
controlling gene clusters 3 and 4, which contain the naïve pluripotency TFs Klf4, Klf5 and Nr0b1, and 34 
the primed markers Sox3 and Dnmt3b, respectively (Table EV2), and are enriched for generic 35 
developmental terms using GO analysis (Figure EV3B). Conversely, cluster 5 and 6 genes were 36 
similarly mis-expressed in Zfp2812i, Zfp28116h and Zfp28132h cells, notably with directionalities that are 37 
inverse to the changes observed in EpiSCs. GO analysis revealed significant enrichment of regulators 38 
of cell adhesion, which is critical for cell polarization (Ebnet et al, 2018) that initiates lumenogenesis 39 
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after exit from naïve pluripotency (Shahbazi et al, 2017). To test if Zfp281 controls polarization, we 1 
generated spheroids in Matrigel as described before (Shahbazi et al, 2017). WT ESCs formed polarized 2 
spheroids with expanded lumens that were encircled by apical F-actin, while Zfp281 KO cells grew as 3 
unpolarized and disorganized cellular aggregates that were morphologically similar to ESCs (Figure 4 
3D). Although we cannot exclude that this is consequential to impaired exit from self-renewal, regulation 5 
of cluster 5 and 6 genes by Zfp281 may therefore contribute to cell polarization and cavity formation 6 
during ESC differentiation. 7 
Oct4, similar to Zfp281, is expressed at equal levels in ESCs and EpiLCs, but occupies distinct CREs 8 
in the two cell states (Buecker et al, 2014). To determine if Zfp281 acts through cell state-specific 9 
chromatin association, we profiled its genome localization in WT2i and WT32h cells using chromatin 10 
immunoprecipitation coupled to deep sequencing (ChIP-seq) (Table EV2). De novo motif finding 11 
identified the consensus CCCCTCCCCC motif in 82.4% of 23756 peaks (Figure EV3C), which is 12 
similar to results obtained in Serum/Lif ESCs (Fidalgo et al, 2016). Surprisingly, Zfp281 occupancy in 13 
WT2i and WT32h cells was as highly correlated (Pearson’s correlation coefficient R = 0.81) as between 14 
replicates (R= 0.84 and R=0.85, respectively), with only few peaks exclusively detected in any of the 15 
two cell states (Figure 3E, EV3D). A lower correlation was observed between WT32h cells and 16 
published data for EpiSCs (Huang et al, 2017) (R=0.69) and trophoblast stem cells (TSCs) (Ishiuchi et 17 
al, 2019) (R=0.55), but binding at peaks associated to cluster 1-6 genes was largely unchanged 18 
(Figure EV3E, F), suggesting stable chromatin association also during later pluripotency progression 19 
and in lineage-unrelated TSCs. To determine if Zfp281 binds to CREs, we profiled histone H3 lysine 20 
27 acetylation (H3K27ac), a chromatin mark associated with active promoters and enhancers. 21 
Comparison of our Zfp281 and H3K27ac with published histone mark ChIP-seq data (Kurimoto et al, 22 
2015; Buecker et al, 2014) (Figure EV3G) identified 7697 Zfp281 peaks proximal to transcriptional 23 
start sites (TSSs), of which 54% were at active promoters (co-localization with H3K27ac and H3K4 tri-24 
methylation), and 16059 distal Zfp281 peaks of which 62% were at putative enhancers (co-25 
localization with H3K4 mono-methylation). 38% of the latter were also enriched for H3K27ac, 26 
qualifying them as active enhancers. Notably, peaks with slightly increased Zfp281 binding in WT32h 27 
cells gained H3K27ac and expression of associated genes during differentiation, while decreased 28 
binding was associated with reduced H3K27ac and transcription (Figure 3F). Despite stable 29 
occupancy of target sites, quantitative binding changes of Zfp281 at these sites therefore parallel 30 
differences in CRE activity. However, this was similar at peaks linked to Zfp281-insensitive cluster 1/2 31 
and -sensitive cluster 3/4 genes (Figure 3G), showing that differential binding strength at CREs 32 
correlates with differentiation-specific gene expression, but only partially with transcriptionally 33 
regulated targets. 34 
Zfp281 interacts with Ehmt1 and Zic2 during ESC differentiation 35 
Since chromatin occupancy was largely unchanged, we reasoned that Zfp281 may control transcription 36 
through cell state-specific protein interaction partners. To test this, we performed Zfp281 37 
immunoprecipitations (IPs) coupled to semi-quantitative mass spectrometry (MS) in nuclear extracts of 38 
WT2i and WT40h cells, including Zfp281 KO lysates to control for antibody-specificity (Table EV3). 39 
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Stringent selection criteria identified the previously reported interactor Nanog (Fidalgo et al, 2012) in 1 
WT2i cells and several proteins specifically enriched in WT40h cells (Figure 4A). Strikingly, the latter were 2 
transcriptionally induced and the former repressed during differentiation (Figure 4B), suggesting that 3 
differential binding to Zfp281 may, at least in part, be driven by protein abundance. To determine 4 
functional downstream effectors, we decided to probe genetic interaction of differentiation-specific 5 
interactors with Zfp281 in our conditionally overexpressing ESCs. To this end we depleted selected 6 
binding partners using siRNA transfection, induced Zfp281 by Dox treatment and quantified Rex1 7 
reporter distribution after 32h in 2i (Figure 4C). As controls, we included siRNAs targeting Zfp281 itself 8 
and Tcf7l1. Transfection of Zfp281 but not Tcf7l1 siRNAs blocked emergence of GFPlow cells (76% 9 
reduction) (Figure 4C, EV4A), thus confirming suitability for identifying genetic Zfp281 interactors. Of 10 
all candidates tested individually, only knockdown of Ehmt1 and Zic2 reduced the fraction of GFPlow 11 
cells (34% and 32%, respectvely), an effect enhanced by simultaneous depletion of both (63%). 12 
Conversely, conditional overexpression of Ehmt1 and Zic2 in RGd2 ESCs (Figure EV4B, C), similar to 13 
Zfp281, induced downregulation of the Rex1 reporter in a subset of cells (Figure EV4D). The de novo 14 
DNA methyltransferases Dnmt3a and Dnmt3b have overlapping functions during embryogenesis 15 
(Okano et al, 1999) and, hence, may act redundantly. However, simultaneous depletion of Dnmt3a and 16 
Dnmt3b by siRNAs or in compound Dnmt3a/3b KO cells (Figure EV4E, F) did not impair Zfp281-induced 17 
reporter repression (Figure 4C, EV4G), demonstrating that Zfp281 drives differentiation independent of 18 
Dnmt3a and Dnmt3b.  19 
Zic2 is a zinc finger TF that represses poised developmental enhancers in Serum/Lif ESCs (Luo et al, 20 
2015). Ehmt1 (GLP) is a methyltransferase that can be found in a complex with Ehmt2 (G9a), which 21 
both mediate mono- and di-methylation of histone H3 lysine 9 (H3K9me1 and H3K9me2) (Tachibana 22 
et al, 2005). The genetic interactions in naïve ESCs (Figure 4C) together with the preferential binding 23 
during differentiation observed in both nuclear extracts using IP-MS (Figure 4A) and whole cell lysates 24 
using IP-western blot (Figure EV4H), suggests that Ehmt1 and Zic2 are functional downstream effectors 25 
of Zfp281. 26 
Ehmt1 and Zic2 regulate ESC differentiation and reprogramming of EpiSCs  27 
We therefore generated individual and compound Ehmt1 and Zic2 KO RGd2 ESCs (Figure EV5A, B). 28 
In contrast to wildtype or Zic2 KO cells, Ehmt1 and Ehmt1/Zic2 KO cells were spindle-shaped (Figure 29 
EV5C) and proliferated slowly (Figure EV5D). They were not arrested at a specific cell cycle stage 30 
(Figure EV5E) and did not exhibit downregulation of the Rex1 reporter in 2i (Figure EV5F). After 2i 31 
withdrawal for 32h (or 72h), 75% (9%) of Ehmt1 and 55% (7%) of Zic2 KO cells maintained GFP 32 
expression, increasing to 90% (35%) in Ehmt1/Zic2 compound KO cells (Figure EV5F), while 30% (1%) 33 
of cells from untargeted sibling clones (Zic2 WT and Ehmt1 WT) were GFPhigh. Correspondingly, 5%, 34 
4% and 12% of Zic2, Ehmt1 and Ehmt1/Zic2 KO cells retained self-renewal after 72h of differentiation 35 
(Figure 5A). Ehmt1 and Ehmt1/Zic2, but not Zic2 KO ESCs, were unable to form polarized spheroids 36 
in Matrigel (Figure 5B). Quantification of this effect was similar to Zfp281 mutants (Figure EV5G). We 37 
therefore conclude that Ehmt1 is required for polarization and that Ehmt1 and Zic2 promote exit from 38 
self-renewal independently of each other. 39 
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In the absence of Ehmt1, H3K9me2 was limited to DAPI-rich speckles (Figure EV5H), which is 1 
reminiscent of the depletion of euchromatic H3K9me2 and its enrichment at pericentric heterochromatin 2 
in Ehmt2 mutants (Tachibana et al, 2002). Since exposure to the Ehmt inhibitors A-366 and UNC0642 3 
induced dose-dependent cell lethality (data not shown), we decided to test Ehmt1’s enzymatic activity 4 
by expressing specific loss of function alleles in Ehmt1 KO cells: An Ehmt1 protein with mutations in 5 
the ankyrin domain (Ehmt1ank), responsible for binding to methylated H3K9 in vitro (Collins et al, 2008), 6 
reverted nuclear H3K9me2 distribution (Figure EV5H) and resistance to Rex1 downregulation (Figure 7 
5C, EV5I) to a similar extent as the wildtype protein did. In contrast, substitutions in the SET domain 8 
(Ehmt1NH-LE) that perturb Ehmt1 methyltransferase in vitro (Tachibana et al, 2008) rescued only partially 9 
and a small deletion in the SET domain (Ehmt1NHHC) that additionally ablates binding to Ehmt2 10 
completely abolished rescue. Therefore, both catalytic activity of Ehmt1 and formation of a larger 11 
methyltransferase protein complex are implicated in ESC transition. 12 
Chemical inhibition and knockdown of Ehmt enzymes in somatic cells enhances reprogramming 13 
(Sridharan et al, 2013; Rodriguez-Madoz et al, 2017; Shi et al, 2008).  Consistently, depletion of Ehmt1 14 
but also of Zic2 in 796.4 and O4GIPGY118F EpiSCs increased Epi-iPSC formation in the presence of Gcsf 15 
(Figure 5D, EV5J). The effect was modest, but enhanced by the combined knockdown of both. Taken 16 
together these results suggest that Ehmt1 and Zic2, similar to Zfp281, drive exit from naïve pluripotency 17 
and restrain reprogramming of EpiSCs. Notably, phenotypes induced by co-depletion of Zic2 and Ehmt1 18 
were weaker than elimination of Zfp281, suggesting existence of additional Zfp281 effectors that may 19 
include other histone modifying complexes (Huang et al, 2017; Zhou et al, 2017; Ishiuchi et al, 2019). 20 
Overlapping transcriptional functions of Zfp281 and Ehmt1/Zic2 21 
To test if the biochemical and functional interaction with Zfp281 is reflected in similar transcriptional 22 
outputs, we profiled mRNA expression in Ehmt1, Zic2 and Ehmt1/Zic2 KO cells in 2i and after 32h of 23 
differentiation (Table EV2). Principle component (PC) analysis, including Zfp281 KO,  EpiLC (Buecker 24 
et al, 2014) and EpiSC (Bao et al, 2018) datasets, of changes relative to WT ESCs identified PC1 to 25 
discriminate developmental timing and to separate differentiated cells from ESCs (Figure 6A). Mutant 26 
and wildtype ESCs projected similarly onto PC1 and expressed pluripotency marker genes at similar 27 
levels (Figure EV6A), confirming their naïve identity. PC2, in contrast, segregated WT from Zfp281 and, 28 
in particular, Ehmt1 KO genotypes. We, indeed, observed 1274 deregulated genes in Ehmt12i cells that 29 
were unchanged in Zfp2812i cells (Figure EV6B). These were enriched for homeostatic and cell 30 
adhesion GO terms (Figure EV6B) and likely contribute to the cellular and polarization phenotypes in 31 
Ehmt1 KO cells. 32 
Progression of Zfp28116h/32h, Ehmt132h and Ehmt1/Zic232h cells along PC1 was impaired when compared 33 
to matching WT controls (Figure 6A), which we also observed in PC analysis using blastocyst 34 
development datasets (Boroviak et al, 2015) (Figure 6B). In fact, alterations in Ehmt1 and Zfp281 KO 35 
cells correlated during differentiation (Figure EV6C), suggesting similar defects in developmental 36 
transcription. This correlation was not strong (R = 0.44), but increased (R=0.57) when only considering 37 
cluster 1-6 gene expression (Figure EV6D). Although we also noted slight deregulation of clusters 1 38 
and 2, transcriptional defects in clusters 3-6 were similar in Ehmt132h and Zfp28132h cells (Figure 6C, 39 
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D). Ehmt2-dependent H3K9 di-methylation is associated with gene silencing (Zylicz et al, 2015), 1 
consistent with the majority of genes showing increased RNA levels in Ehmt12i cells (Figure EV6B). 2 
Nevertheless, 38% of target genes were downregulated. Changes in the absence of Ehmt1 are 3 
therefore likely consequential to both direct and indirect effects and may also include the contribution 4 
of non-histone Ehmt1 substrates (Sim et al, 2017) to transcription. 5 
Based on mRNA levels, Zic232h cells were not separated from matching control cells (Figure 6A-D). 6 
This was surprising, since Zic2 KO cells appeared similarly impaired in exiting self-renewal as Ehmt1 7 
KO cells (Figure 5A). However, loss of Zic2 in Ehmt132h cells enhanced the deregulation of clusters 1-8 
4 during differentiation (Figure 6D) and induced a shift along PC1 (Figure 6A, B). Linear regression 9 
revealed that perturbations in Ehmt1/Zic2 KO cells were predominantly the sum of alterations in single 10 
mutants rather than synergistic (Figure EV6E), implying subtle, but functionally relevant changes in Zic2 11 
KO cells. Ehmt1 and Zic2 therefore regulate transcription independently of each other, aligning with 12 
their additive loss-of-function phenotypes in differentiation and reprogramming (Figure 5A, D). Taken 13 
together, this analysis demonstrates connected functions of Zfp281 and Ehmt1/Zic2 in gene expression 14 
during cell state transition. 15 
Ehmt1 and Zic2 act downstream of Zfp281 on chromatin 16 
To identify direct targets and to explore how those relate to the physical interaction with Zfp281 in 17 
differentiated cells, we performed Zic2 and Ehmt1 ChIP-seq, and profiled H3K9me2 as a proxy for 18 
Ehmt1 activity. Due to absence of ChIP-seq compatible Ehmt1 antibodies, we inserted an N-terminal 19 
Flag-Avi tag at both Ehmt1 alleles in ESCs expressing the BirA biotin ligase (Figure EV7A). This did 20 
not perturb exit from self-renewal (Figure EV7B), indicating expression of a functional Ehmt1 fusion 21 
protein (Bio-Ehmt1). ChIP-seq using Streptavidin beads identified broad Ehmt1-occupied chromatin 22 
domains that, consistent with an enzyme-substrate-relationship, scaled with H3K9me2 genome-wide 23 
(Figure EV7C). To determine overlap with Zfp281, we quantified Ehmt1 and H3K9me2 enrichment at 24 
Zfp281-bound and matching unbound control windows (see methods for details). Ehmt1 localization at 25 
both sets of regions was unchanged during differentiation or in Zfp281 KO cells (Figure EV7D, E), 26 
indicating that Zfp281 is not required for Ehmt1 localization on chromatin. In contrast to Ehmt1, 27 
H3K9me2 increased in WT32h cells and EpiLCs (Kurimoto et al, 2015), with a more pronounced increase 28 
at Zfp281-occupied loci than control windows (Figure 7A). To test if these dynamics require Zfp281, we 29 
performed immunofluorescence staining which revealed that mutant cells failed to gain H3K9me2 by 30 
32h after 2i withdrawal (Figure EV7F). H3K9me2 ChIP-seq in Zfp281 mutants confirmed that H3K9me2 31 
levels were unaffected in Zfp2812i cells but did not increase in Zfp28132h cells (Figure 7A, EV7E). 32 
Impaired gain of H3K9me2 was observed at both Zfp281-bound and -unbound sites, suggesting that 33 
Zfp281 is a differentiation-specific pervasive activator of Ehmt1 during ESC transition. Zic2 ChIP-seq 34 
identified 28495 peaks, of which approximately 30% overlapped with Zfp281 (Figure 7B). These were 35 
closer to promoters and enriched for H3K27ac compared to Zic2-only and Zfp281-only peaks (Figure 36 
EV7G, H), suggesting co-localization of Zfp281 and Zic2 at CREs. In WT32h cells, Zic2 increased 37 
predominantly at co-bound peaks (Figure 7B). Although we noted a general reduction of Zic2 on 38 
chromatin in Zfp281 mutants, Zic2 localization was particularly perturbed at co-bound sites in Zfp28132h 39 
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cells (Figure 7B, EV7I). Our findings therefore suggest that Zfp281 engages Ehmt1 and Zic2 during 1 
ESC differentiation through chromatin co-occupancy-dependent and -independent mechanisms. 2 
At Zfp281-bound peaks, the gain of H3K9me2 and Zic2 occurred mostly at mutually exclusive sets of 3 
genomic loci with reduced and increased Zfp281 binding during differentiation, respectively (Figure 7C, 4 
D), indicating that these are sites of direct physical interaction that control transcription of nearby genes. 5 
We therefore stratified H3K9me2 and Zic2 binding dynamics at Zfp281 peaks by gene cluster 6 
association. H3K9me2 increased predominantly at peaks linked to repressed clusters 1 and 3, and Zic2 7 
at peaks belonging to induced clusters 2 and 4 (Figure 7E). Surprisingly, the gain in WT32h cells and 8 
reduction in Zfp28132h cells was indistinguishable between clusters 1 and 3 (for H3K9me2) and clusters 9 
2 and 4 (for Zic2). Hence, Zfp281 catalyzes H3K9me2 and Zic2 deposition at transition-associated 10 
CREs genome-wide and without any qualitative or quantitative specificity for its transcriptional targets 11 
in clusters 3 and 4. Why cluster 1 and 2 gene expression is insensitive to perturbation of H3K9me2 and 12 
Zic2 dynamics in Zfp281 KO cells (Figure 3C, 7E) remains to be determined. Additional chromatin 13 
regulators may be involved, since transcription of clusters 1 and 2 is also less sensitive to Ehmt1 14 
depletion than of clusters 3 and 4 (Figure 6D). We therefore propose that Zfp281 drives and stabilizes 15 
transition-specific transcription, at least in part, through activation of Ehmt1 at cluster 3 CREs and 16 
recruitment or stabilization of Zic2 at cluster 4 CREs. 17 
 18 
DISCUSSION 19 
Cellular plasticity in response to injury in vivo or TF overexpression in vitro is frequently accompanied 20 
by the reversal of cellular specialization (Merrell & Stanger, 2016). Although single cell profiling has 21 
shown that this process is not a strict inversion of natural development (Gerber et al, 2018; Treutlein et 22 
al, 2016), differentiation and de-differentiation trajectories may mechanistically intersect. We aimed to 23 
uncover such plasticity regulators in pluripotent cells and performed loss-of-function screening for 24 
genes that both drive exit from ESC self-renewal, and shield EpiSCs from reprogramming into the 25 
pluripotent ground state. Within the experimental limitations of this approach we identified only one 26 
gene, the TF Zfp281. Such exclusivity suggests a prominent role in establishing and maintaining the 27 
unidirectionality of pluripotent cell state progression in vitro. The former is consistent with perturbed 28 
epiblast maturation in Zfp281 mutant embryos (Huang et al, 2017), but if Zfp281 protects cellular 29 
identities against de-differentiation in vivo remains to be determined. We, however, note that Zfp281 30 
restrains iPSC formation from fibroblasts at a late pre-iPSC stage (Fidalgo et al, 2012), supporting the 31 
notion that resetting of EpiSCs into naïve pluripotency recapitulates a late phase of somatic cell 32 
reprogramming (Dunn et al, 2019). Other factors that, similar to Zfp281, drive differentiation and inhibit 33 
de-differentiation of cell states not represented in our ESC-EpiSC conversion system are likely to exist. 34 
We showed that Zfp281 is important for robust ESC differentiation. This is reminiscent of lineage-35 
specifying TFs, that are specifically expressed in the lineages they instruct (Graf & Enver, 2009). In 36 
adult mice, Zfp281 is indeed transcribed strongest in heart tissue and its overexpression in fibroblasts 37 
enhances cardiac reprogramming (Zhou et al, 2017). During ESC differentiation, however, Zfp281 38 
neither changes expression nor occupies distinct genomic sites, indicating a facilitating, rather than 39 
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specifying, function. Using biochemical, genetic and genomic experiments we provide evidence that 1 
Zfp281 directs sequential gene expression through permissive and instructive mechanisms involving 2 
physical interaction with Ehmt1 and Zic2. Cluster 5 and 6 genes are differentially expressed in EpiSCs, 3 
but transcriptionally primed by Zfp281 throughout differentiation, including in the naïve pluripotent 4 
starting cell state. Cluster 5 contains modulators of cell adhesion that may contribute to polarization of 5 
post-implantation epiblast cells. However, although Zfp281 null embryos degenerate during 6 
gastrulation, they do form an epithelial egg cylinder (Huang et al, 2017), suggesting operation of 7 
compensatory mechanisms in vivo. Cluster 3 and 4 genes are, in contrast, regulated by Zfp281 8 
predominantly during transition, enriched for developmental functions, and, therefore, likely responsible 9 
for extinguishing ESC identity.  Strikingly, Zfp281 quantitatively decreases at CREs associated with 10 
repressed cluster 3 genes and, vice versa, increases at CREs associated with induced cluster 4 genes. 11 
Concomitant gain of H3K9me2 and Zic2 at cluster 3 and 4 CREs, respectively, suggests that subtle 12 
Zfp281 chromatin binding differences are converted into CRE activity changes by reciprocal activation 13 
of Ehmt1 and Zic2. Consistently, embryonic arrest in Ehmt1 and Ehmt2 mutant mouse embryos 14 
(Tachibana et al, 2002; 2005) has been attributed to reduced H3K9me2 deposition at and impaired 15 
silencing of developmental enhancers (Zylicz et al, 2015), while Zic2 triggers neural plate gene 16 
expression in EpiSCs through enhancer activation (Iwafuchi-Doi et al, 2012). The molecular 17 
mechanisms inducing differential binding of Zfp281 to Ehmt1 and Zic2 remain to be elucidated. Because 18 
of similar overexpression phenotypes in ESCs we surmise that protein ratios are rate-determining. Zic2 19 
protein levels, despite unchanged mRNA (Figure 4B), indeed increase during differentiation, while 20 
Ehmt1 persists (Figure EV4H). However, Ehmt1 and Ehmt2 interact with additional zinc finger TFs 21 
(Shinkai & Tachibana, 2011) that may compete with Zfp281 for binding to Ehmt1 specifically in ground 22 
state ESCs. Taken together, we suggest that Zfp281 promotes stable cell state transition by 23 
permissively marking cluster 5 and 6 genes for forthcoming developmental regulation, and instructing 24 
cluster 3 and 4 gene expression for elimination of naïve pluripotency, the latter through differential 25 
engagement with Ehmt1 or Zic2 at CREs. 26 
Zfp281 drives differentiation to and inhibits reprogramming of EpiSCs, and therefore qualifies as a 27 
bidirectional cell state regulator with antipodal functions during developmental progression and 28 
reversion. If this is because Zfp281-Ehmt1/Zic2 control the same cell state transition and act through 29 
the same target genes in mutual directions remains to be determined. We showed that Zfp281 KO cells 30 
exposed to differentiation-promoting conditions are less clonogenic than ESCs and give rise to an 31 
equilibrium of Rex1high and Rex1low cell states that features defective coupling of Rex1 downregulation 32 
with exit from self-renewal. It is therefore conceivable that Zfp281 acts after an initial commitment step 33 
to induce and stabilize irreversible silencing of naïve identity. During reprogramming, Zfp281 may 34 
inversely antagonize induction of naïve pluripotency prior to formation of a Rex1high state, which has 35 
recently been shown to mark transition intermediates with full ESC self-renewal activity and destined to 36 
give rise to Epi-iPSCs (Stuart et al, 2019). Acting at a late stage of reprogramming also reconciles our 37 
finding of Zfp281 impairing Epi-iPSC formation by STAT3 activation and Esrrb overexpression (Figure 38 
1G, EV1F) with the notion that both regimes proceed along distinct transcriptional trajectories before 39 
converging on a Rex1high cell state (Stuart et al, 2019). However, Zfp281 depletion in EpiSCs also 40 
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causes cell cycle arrest and apoptosis (Fidalgo et al, 2016), but not upregulation of naïve pluripotent 1 
TFs such as Nanog (Figure EV2O), and is not alone sufficient for reprogramming to Epi-iPSCs in the 2 
presence of 2i (Figure 1F). Zfp281 activates transcription of Nodal signaling components, such as the 3 
cluster 5 genes Lefty1 and Lefty2, in ESCs, EpiSCs and the post-implantation epiblast (Huang et al, 4 
2017). Nodal signaling is required for EpiSC maintenance (Vallier et al, 2009), but dispensable for exit 5 
from ESC self-renewal (Mulas et al, 2017) and somatic cell reprogramming (Ruetz et al, 2017). We 6 
therefore speculate that Zfp281 controls the EpiSC state and reprogramming through different effector 7 
genes. The former through regulation of cluster 5/6 genes, e.g. Lefty1, Lefty2 or cell polarity regulators, 8 
and the latter through stabilization of cell state transition-specific cluster 3/4 genes. 9 
In metastable Serum/Lif ESCs, Zfp281 is reported to promote DNA methylation and differentiation by 10 
recruiting Tet1 and silencing Tet2 (Fidalgo et al, 2016). Upon exit from the naïve ESC state, Zfp281 11 
binds to Dnmt3a, Dnmt3b and Dnmt3l (Figure 4A), suggesting that Zfp281 controls 5-methylcytosine 12 
turnover through regulating DNA methylating and demethylating enzymes. Furthermore, Dnmt1, 13 
Dnmt3a and Dnmt3b interact with the Ehmt1-Ehmt2 heterodimer (Epsztejn-Litman et al, 2008; Estève 14 
et al, 2006), H3K9me2 and 5-methylcytosine marks overlap genome-wide (Meyenn et al, 2016) and 15 
DNA is hypomethylated upon depletion or catalytic inhibition of Ehmt2 in ESCs (Zhang et al, 2016b). 16 
We, however, showed that Zfp281 drives exit from naïve pluripotency independent of Dnmt3a, Dnmt3b, 17 
Tet1 and Tet2. Although the specific contributions of 5-methylcytosine, H3K9me2, and other Ehmt 18 
substrates (Sim et al, 2017) to pluripotent cell plasticity remain to be determined, our findings suggest 19 
that resolution of naïve pluripotency in vitro is masked or mechanistically distinct in heterogeneous 20 
Serum/Lif ESC cultures. Similarly, Zic2 has previously been reported to act as a repressor in metastable 21 
Serum/Lif ESCs (Luo et al, 2015), but we detect only minor transcriptional defects in naïve Zic2 KO 22 
ESCs. 23 
Using the paradigm of pluripotent cell state conversion in vitro, we here identify, in Zfp281, a regulator 24 
of cellular plasticity that modulates CRE activity and transcription without reliance on cell type-restricted 25 
expression or chromatin occupancy. We propose that the persistence of Zfp281 at developmental CREs 26 
throughout cell state transition provides a molecular platform for ordered remodeling of the cis-27 
regulatory architecture and further consolidation by lineage-specifying TFs. These findings demonstrate 28 
that differential gene expression is not a necessary criterion of cellular plasticity regulators and we 29 
suggest that this feature may not be limited to pluripotent cells.  30 
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MAIN FIGURES 1 
 2 
Figure 1: Zfp281 inhibits reprogramming of EpiSCs. 3 
(A) Schematic outline of the reprogramming screen. Red indicates O4GiPGY118F EpiSCs and green 4 
O4GIPGY118F Epi-iPSCs. 5 
(B) Average Z scores of the two screen replicates. Note that esiRNAs targeting Mll1 (Zhang et al, 6 
2016a) and Mbd3 (Rais et al, 2013) were not included in our library and that Otx2 (Acampora et al, 7 
2013) scored below the significance threshold. Screen hits with negative (blue) and positive (red) Z 8 
scores (red), and Tcf7l1 (green) are highlighted. 9 
(C) Comparison of reprogramming screen hits with two ESC differentiation screens (Betschinger et al, 10 
2013; Li et al, 2018). Empty and full circles indicate genes recovered in one and both ESC differentiation 11 
screens, respectively.   12 
(D) Number of Epi-iPSC colonies derived from 796.4 EpiSCs transfected with indicated siRNAs, 13 
stimulated with Gcsf and 2i for 4d, and selected with Puromycin. Average and standard deviation (SD) 14 
of 3 experiments performed in duplicates. Negative siRNA (neg). 15 
 23 
(E) Self-renewal of O4GIPGY118F reprogramming intermediates after 2d or 4d of stimulation with Gcsf 1 
and 2i following transfection with indicated siRNAs. Average and SD of 2 experiments performed in 2 
duplicates. 3 
(F) Number of Epi-iPSC colonies derived from OEC2 EpiSCs transfected with indicated siRNAs, treated 4 
for 4d in 2i or 2i/Lif medium, and selected with Puromycin. Average and SD of 2 experiments performed 5 
in duplicates. 6 
(G) Number of Epi-iPSC colonies derived from O4GIP EpiSCs carrying Dox-inducible Esrrb or Klf4 7 
transgenes after transfection with indicated siRNAs, stimulation with or without Dox for 2d, and selection 8 
with Puromycin. Average and SD of 2 experiments performed in duplicates.  9 
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 1 
Figure 2: Zfp281 drives exit from naïve pluripotency independent of Tet enzymes. 2 
(A, B, E) Self-renewal in RGd2 ESCs of specified genotypes expressing indicated transgenes (B) after 3 
differentiation in indicated conditions (A) or 72h in N2B27 (B, E). Average and SD of 2 experiments 4 
performed in duplicates. Note that control cells were lost during continuous passaging in N2B27 (A). 5 
Not determined (n.d.). 6 
(C) Representative flow cytometry profiles of WT and Zfp281 KO.1 cells after 32h of 2i withdrawal 7 
before (unsorted) and after purification of cells with indicated GFP expression (top panel). Self-renewal 8 
 25 
of undifferentiated (2i) and sorted GFPhigh,sort and GFPlow,sort cells of indicated genotypes (bottom panel). 1 
Average and SD of 3 experiments performed in duplicates. 2 
(D) Representative flow cytometry profiles of control and Zfp281-inducible ESCs (top panel) and 3 
quantification of GFPlow cells (bottom panel) after 2d in 2i and in the presence (green) or absence (black) 4 
of Dox. Average and SD of 2 experiments. 5 
(F) Zfp281 mRNA changes during ESC differentiation detected by quantitative PCR (left) and extracted 6 
from published RNA-seq datasets (Buecker et al, 2014; Factor et al, 2014; Boroviak et al, 2015; Bao et 7 
al, 2018) (right). Average and SD of 2 technical replicates (left).   8 
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 1 
Figure 3: Zfp281 directs sequential gene expression despite stable occupancy of target sites. 2 
(A) mRNA log2 fold changes (log2FC) in WT16h, WT32h, Zfp28116h and Zfp28132h samples relative to 3 
WT2i cells, and in EpiSCs relative to WT2i/Lif cells (Factor et al, 2014; Bao et al, 2018). Zfp2812i, 4 
Zfp28116h, Zfp28132h and WT16h and WT32h samples were used for k-means clustering. 5 
(B, C) Quantification of (A) including mRNA log2FC in EpiLCs relative to WT2i/Lif (Buecker et al, 2014) 6 
and as indicated (C). 7 
 27 
(D) Representative immunofluorescence staining of spheroids in Matrigel derived from WT or Zfp281 1 
KO.1 ESCs grown in 2i or N2B27 for 3d. Blue: DNA. Red: F-actin. Scale bar is 10µm. 2 
(E) Scatter plot comparing Zfp281 log2 ChIP enrichment relative to matched inputs in WT2i and WT32h 3 
cells. 4 
(F) Same as in (E) with dots colored according to H3K27ac ChIP log2FC at the same peaks (top left), 5 
and to gene expression log2FC associated with peaks by nearest distance to TSS (bottom left) in WT32h 6 
relative to WT2i cells. Quantification of H3K27ac ChIP (top right) and mRNA (bottom right) log2FC at 7 
top 1000 Zfp281 peaks with increased (red) or decreased (blue) Zfp281 binding during ESC 8 
differentiation. 9 
(G) Quantification of Zfp281 (left) and H3K27ac (right) ChIP log2FC in WT32h compared to WT2i cells at 10 
Zfp281 peaks assigned to gene clusters 1-6.  11 
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 1 
Figure 4: Zfp281 acts by associating with Ehmt1 and Zic2. 2 
(A) Cell state-specific Zfp281 interactors in WT2i and WT40h cells. Pink and cyan mark Zfp281 and 3 
selected binding partners, respectively. Quantification is based on 3 biological replicates. 4 
(B) Same as (A) with mRNA log2FC of differential binding partners during ESC differentiation instead 5 
of p-values. 6 
(C) Procedure to identify Zfp281 effectors in naïve Zfp281-inducible RGd2 cells (left). Quantification of 7 
GFPlow WTind. Zfp281 cells transfected with indicated siRNAs and incubated for 32h in 2i in the presence 8 
(green) or absence (black) of Dox (right). Dashed line marks fraction of GFPlow cells in control cells 9 
exposed to Dox. Significance was determined using a Wilcoxon Mann-Whitney rank sum test compared 10 
to neg control sample. (*) <0.05; not significant (n.s.). Average and SD of 4 experiments.  11 
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 1 
Figure 5: Ehmt1 and Zic2 drive exit from the ESC state and restrict reprogramming of EpiSCs. 2 
(A) Self-renewal in cells with indicated genotypes 3d after 2i withdrawal. Significance was determined 3 
using a Wilcoxon Mann-Whitney rank sum test comparing the specified genotype groups. (*) <0.05. 4 
Average and SD of 2 experiments performed in duplicates. 5 
(B) Representative immunofluorescence staining of spheroids in Matrigel derived from indicated 6 
genotypes in 2i or N2B27 for 4d. Blue: DNA. Red: F-actin. Scale bar is 10µm.  7 
(C) Quantification of GFPhigh cells in WT cells or Ehmt1 KO clones expressing indicated transgenes in 8 
2i (black) or 32h after 2i withdrawal (pink). Average and SD of 2 experiments. 9 
(D) Number of Epi-iPSC colonies derived from 796.4 (grey) and O4GIPGY118F (black) EpiSCs transfected 10 
with indicated siRNAs, stimulated with Gcsf and 2i for 4d, and selected with Puromycin. Significance 11 
was determined using a Wilcoxon Mann-Whitney rank sum test compared to neg control sample of the 12 
respective cell line, or comparing Zic2 and Ehmt1 to Ehmt1/Zic2 depletion. (*) <0.05. Average and SD 13 
of 5 experiments performed in duplicates.  14 
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 1 
Figure 6: Related transcriptional defects in Ehmt1/Zic2 and Zfp281 KO cells. 2 
(A, B) PC analysis of indicated samples normalized to WT ESCs (A) and all samples (B) within each 3 
dataset. Arrows indicate developmental trajectories. Full and dashed outlines indicate independent 4 
RNA-seq experiments. 5 
(C, D) Quantification of cell state-specific mRNA log2FC of gene clusters 1-6 between indicated 6 
genotypes in 2i (C) and 32h after 2i withdrawal (D).  7 
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 1 
Figure 7: Zfp281 engages with Ehmt1 and Zic2 at developmental CREs. 2 
(A) H3K9me2 ChIP log2FC between indicated cell states and genotypes at 10kb windows surrounding 3 
Zfp281-bound (purple) or matching DNAse-hypersensitive site (DHS) control peaks (grey). 4 
(B) Overlap of Zfp281 and Zic2 ChIP peaks (left) and Zic2 ChIP log2FC between specified cell states 5 
and genotypes at indicated peak subsets (right). 6 
(C, D) Same as in Figure 3F. Coloring is according to H3K9me2 ChIP log2FC between WT32h and WT2i 7 
cells (C, top left) and between EpiLCs and WT2i/Lif cells (C, bottom left) at Zfp281 peaks extended to 8 
10kb windows, and according to Zic2 ChIP log2FC between WT32h and WT2i cells (D, left). 9 
 32 
Quantification of corresponding ChIP changes at top 1000 Zfp281 peaks with increased (red) or 1 
decreased (blue) Zfp281 binding during ESC differentiation (right).  2 
(E) H3K9me2 (top) and Zic2 (bottom) ChIP log2FC between indicated cell states and genotypes at all 3 
Zfp281 peaks extended to 10kb windows (top) or Zfp281/Zic2 co-bound peaks (bottom) associated with 4 
nearest TSSs of cluster 1-6 genes.  5 
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MATERIALS AND METHODS 1 
Cell Culture 2 
ESCs (male and female RGd2 cells containing a Rex1:GFPd2-IRES-Blasticidin (Wray et al, 2011), male 3 
O4GIP ESCs contain a GFP-IRES-Puromycin transgene under control of an Oct4 regulatory element 4 
(Betschinger et al, 2013) and male E14 cells) were cultured on plastic coated with gelatin or laminin 5 
(Sigma) in N2B27 medium (DMEM/F12 (Life Technologies), Neurobasal (Gibco) supplemented with N2 6 
(homemade) and B-27 Serum-Free Supplement (Gibco), 2mM L-glutamine (Gibco), and 0.1mM 2-7 
mercaptoethanol (Sigma)) with 2i (3µM CHIR99021 and 1µM PD0325901 (Steward lab, Dresden)), 8 
and, where indicated, with 1µg/ml  Doxycycline (Sigma). EpiSCs (O4GIP and OEC2 (Guo et al, 2009) 9 
and 796.4 (Yang et al, 2010)) were cultured on plastic coated with fibronectin (Millipore) in N2B27 with 10 
bFGF (12ng/ml) and ActivinA (20ng/ml) (FA) (Smith lab, Cambridge). 11 
For monolayer differentiation, ESCs were seeded on gelatin-coated plates at 1.5 x 104 cells/cm2 in 2i 12 
and the following day 2i was withdrawn. Cells were incubated in N2B27 for 32 hours (h) or 72h, or 13 
continuously passaged on laminin-coated plates, as indicated. For EpiLC differentiation for 48h 14 
(Hayashi et al, 2011), medium was adjusted to FA and 1% knockout serum replacement (Thermo 15 
Fisher). For embryoid body (EB) differentiation, ESCs were seeded at 2.5 x 104 cells/cm2 on ultra-low 16 
attachment plates (Corning) in Serum media (GMEM (Sigma) supplemented with 10% fetal bovine 17 
serum (Sigma), 1mM sodium pyruvate (Gibco), 2mM L-glutamine (Gibco), 0.1mM non-essential amino 18 
acids (Gibco), and 0.1mM 2-mercaptoethanol (Sigma)) for 72h.  Exit from pluripotency was quantified 19 
by measuring GFP fluorescence in RGd2 cells on a LSRII SORP Analyzer (Becton Dickinson) and 20 
analyzed using FlowJo (FlowJo, LLC), and by performing self-renewal and commitment assays as 21 
described before (Betschinger et al., 2013). Briefly, differentiated RGd2 and E14 cells at indicated time 22 
points were plated at clonal density on laminin-coated plates in 2i medium, resulting colonies stained 23 
for alkaline phosphatase activity (Sigma) according to the manufacturer’s instruction, and counted. 24 
RGd2 cells were additionally selected with 10µg/ml Blasticidin (Thermo Fisher). O4GIP cells were 25 
differentiated for 72h, treated with 2i medium containing 1µg/ml Puromycin (Gibco) and uncommitted 26 
cells quantified after 3 days by adding 1:10 diluted Alamar Blue (Invitrogen) in 2i medium, following by 27 
read out on a SpectraMax Gemini EM (Molecular Devices) microplate reader. For cell cycle analysis, 28 
cells were fixed in cold 70% ethanol for 30 minutes (min) at 4°C, washed twice with PBS and 0.1% BSA 29 
(Sigma), treated with 5µg RNaseA (Thermo Fisher) for 15min at room temperature (RT) and stained 30 
with 10µg propidium iodide (Sigma). Cells were analyzed on a LSRII SORP Analyzer and cell cycle 31 
distributions determined using FlowJo. 32 
siRNA transfections were performed as described (Betschinger et al, 2013) using 16.7nM siRNA 33 
(detailed in Table EV4) and transfection mixes in OptiMEM (Invitrogen) containing Lipofectamine 2000 34 
or RNAiMAX (Thermo Fisher) for ESCs or EpiSCs, respectively.  35 
For EpiSC reprogramming, cells were plated at 1.5 x 104 cells/cm2 on fibronectin-coated plates in N2B27 36 
with FA. The next day, medium was change to 2i and, as indicated, supplemented with 30ng/ml 37 
granulocyte colony stimulating factor (Gcsf) (Peprotech), 10ng/ml Lif (Smith lab, Cambridge) or 1µg/ml 38 
Doxycycline. After 4 days (d), medium was changed to 2i with 1µg/ml Puromycin, Epi-iPSC colonies 39 
 34 
were stained for alkaline phosphatase activity, and counted. For experiments shown in Figure 1E and 1 
EV1A, cells were subjected to self-renewal assays in 2i after 2 and 4d of Gcsf supplementation. For 2 
experiments shown in Figure EV1E, individual Epi-iPSC colonies were picked and expanded in 2i with 3 
Puromycin for further experiments. 4 
Spheroid formation of ESCs was performed as described before (Shahbazi et al, 2017). Briefly, ESCs 5 
grown in 2i medium were washed in N2B27, 7.5 x 103 cells were resuspended in 25µl ice-cold growth 6 
factor reduced Matrigel (Corning, 356231), plated dropwise on uncoated 96 well glass plates (Greiner 7 
Bio-One), and aggregated in N2B27 with or without 2i for 3 or 4d.  8 
EpiSC screen 9 
O4GIPGY118F EpiSCs were reverse-transfected in fibronectin-coated 384 well plates using mixtures of 10 
50ng esiRNA and 0.075μl Lipofectamine 2000 in 10μl OptiMEM medium. EpiSCs were plated at a 11 
density of 5000 cells/well in 80µl N2B27 with FA. Each plate included three negative (Luciferase 12 
esiRNA) and two positive (Stat3 esiRNA) control wells. The next day, medium was changed to 2i 13 
containing 30ng/ml Gcsf and 4d later to 2i containing 1µg/ml Puromycin. After 3-4d, medium was 14 
changed to 2i containing 1/10 vol Alamar Blue (Invitrogen) and cell survival quantified on a SpectraMax 15 
M2 (Molecular Devices). 16 
Genome editing 17 
CRISPR/Cas9 genome editing was performed by transient co-transfection of hCas9 and U6-gRNA 18 
plasmids (Mali et al, 2013) (Addgene plasmids 41815 and 41824) and a dsRed expression plasmid into 19 
E14 or female RGd2 ESCs.  2d later, single dsRed positive cells were sorted into gelatin-coated 96 well 20 
plates containing Serum media supplemented with 10ng/ml Lif and 2i. Clones were genotyped by 21 
sequencing amplified target loci, and by confirming protein absence in Western blots. For generation of 22 
knockout (KO) cell lines, two independent KO clones (specified in Figure EV2A and J, EV4E and EV5A) 23 
and, in the case of Zfp281, Ehmt1 and Zic2 targeting, one untargeted wildtype sibling clone were kept 24 
for further analysis. 25 
N-terminal Flag-Avi tagging of Ehmt1 was performed in WT or Zfp281 KO ESCs constitutively 26 
expressing the BirA biotin ligase (see below). The recombination template was generated by cloning 27 
homology arms (548bp up- and 618bp downstream of the Ehmt1 transcription start site) into 28 
pDONR221 using Gateway technology (Thermo Fisher) and inserting the Flag-Avi sequence by 29 
Seamless Cloning (Thermo Fisher). Targeting was performed as above with hCas9, U6-gRNA and 30 
dsRed expression plasmids, but included co-transfection of the recombination template, and genotyping 31 
the presence of biotinylated Ehmt1 using Western blots. 32 
gRNA sequences, genotyping primers and the Ehmt1 recombination template are specified in Table 33 
EV4. gRNA sequences targeting Tet1 and Tet2 (Wang et al, 2013) and Dnmt3a and Dnmt3b (Domcke 34 
et al, 2015) have been described.  35 
Immunostaining 36 
 35 
Cells seeded on laminin-coated 96 well glass plates were fixed with 4% paraformaldehyde (Electron 1 
Microscopy Sciences) for 10min and spheroids grown in Matrigel for 20min at RT. Samples were 2 
blocked for 1h in blocking solution (PBS, 0.1% TritonX (Sigma), 3% donkey serum (Sigma), and 1% 3 
BSA) and incubated overnight with primary antibodies (Ehmt1 (Abcam, ab41969, 1:300) and H3K9me2 4 
(Abcam, ab1220, 1:300)) at 4°C. After three washes in washing solution (PBS, 0.1% TritonX), 5 
secondary antibodies were added, DNA stained with Hoechst33342 (Life Technologies) and, where 6 
indicated, incubated with Alexa Fluor 488 Phalloidin (Life Technologies, A12379, 1:40) for 20min at RT. 7 
Images were acquired using a LSM 710 scanning head confocal microscope (Zeiss) at 20x 8 
magnification and handled using Fiji and Adobe Photoshop (Adobe). Imaging of spheroids used for 9 
quantification in Figure EV5G was performed with a Yokogawa CV7000s high throughput confocal 10 
microscope at 20x magnification. Images were acquired in confocal mode as z-stack multiplane images 11 
over z distance of 50 µm with a 5 µm step size and maximum intensity projections were stored, 12 
representatives of which are shown in Figure 5B. 13 
Molecular biology 14 
Coding sequences for Ehmt1, Esrrb, Klf4 and Zfp281 were amplified from ESC complementary DNA 15 
(cDNA) and for BirA biotin ligase from a plasmid (gift of Matyas Flemr, Friedrich Miescher Institute, 16 
Basel). For Zic2, the coding sequence was synthesized as a double-stranded gBlock (IDT). 17 
Polynucleotides were recombined into pDONR221 using Gateway technology. Ehmt1 point mutations 18 
(Ehmt1ΔNHHC: NHHC1198-1201del (Tachibana et al, 2008), Ehmt1NH-LE: NH1198-1199LE (Tachibana et 19 
al, 2008), and  Ehmt1ank: W872A, W877A, E880A (Collins et al, 2008)) were introduced by polymerase 20 
chain reaction (PCR). Expression destination vectors were pPB-CAG-DEST-pgk-hph (Betschinger et 21 
al, 2013) and pPB-TRE-DEST-rTA-pgk-hph (Villegas et al, 2019), and GY118F expression vector as 22 
described (Yang et al, 2010). Stable integration into ESCs or EpiSCs after co-transfection with pBASE 23 
(Betschinger et al, 2013) was selected in the presence of 150µg/ml HygromycinB (Thermo Fisher). 24 
For relative mRNA quantification, total RNA was isolated from indicated samples using RNeasy Mini 25 
Kit (Qiagen) and cDNA prepared using SuperScript III reverse transcriptase (Invitrogen). Quantitative 26 
PCR was performed using TaqMan Fast Universal PCR master mix (Applied Biosystems) with gene 27 
specific primers, either using the universal probe library (UPL, Roche) or Taqman system (Applied 28 
Biosystems), and a GAPDH probe (Applied Biosystems) for normalization. Oligonucleotide sequences 29 
and probes are listed in Table EV4. 30 
Protein methods 31 
Cell lysates for Western blotting were generated in RIPA buffer (50mM Tris, pH 7.4, 150mM NaCl, 1mM 32 
EDTA, 1% Tx-100, and 0.1% SDS). Primary antibodies were anti-GAPDH (Sigma, G8795, 1:5000), 33 
anti-Ehmt1 (Abcam, ab41969, 1:500), anti-Tet1 (Millipore, 09-872, 1:1000), anti-Tet2 (Abcam, 34 
ab124297, 1:300), anti-Zic2 (Abcam, ab150404, 1:500), anti-Zfp281 (Bethyl Laboratories, A303-118A, 35 
1:500), and anti-Streptavidin coupled to HRP (Sigma, EV2438, 1:1000). 36 
Nuclear immunoprecipitations (IPs) for Zfp281 were performed in three biological replicates using WT2i, 37 
Zfp2812i, WT40h and Zfp28140h cells. Cells were washed with cold PBS, resuspended in 5 packed cell 38 
 36 
volume (pcv) of buffer A (10mM HEPES pH 7.9, 1.5mM MgCl2, and 10mM KCl), incubated for 10min 1 
on ice, and broke open using a Dounce homogenizer. Nuclei were pelleted at 3300g for 15min at 4°C, 2 
resuspended in 3 pcv of buffer B (20mM HEPES pH 7.9, 1.5mM MgCl2, 0.2mM EDTA, and 20% 3 
glycerol) supplemented with 420mM NaCl, Complete Mini protease, PhosSTOP phosphatase inhibitors 4 
(Roche) and 250U/ml Benzonase (Sigma), and incubated for 30min at 4°C on a rotating wheel. 5 
Insoluble material was pelleted at 25000g for 30min at 4°C, and the supernatant diluted with buffer B 6 
to a final concentration of 150mM NaCl and including 0.02% NP40. 1% of the supernatant was kept as 7 
input sample and the remainder incubated with 10µl Dynabeads ProteinG (Invitrogen) and 1µg Zfp281 8 
antibody (Bethyl Laboratories, A303-118A) for 1h at 4°C on a rotating wheel. Beads were collected on 9 
a magnetic rack for 2–3min to remove the supernatant, and washed 4 times in 1ml buffer B containing 10 
150mM NaCl and 0.02% NP40 for 10min each at 4 °C on a rotating wheel. For mass spectrometry, 11 
proteins were digested on the beads as described before (Villegas et al, 2019).  12 
Whole cell lysate IPs using 1µg Zfp281 antibody (Bethyl Laboratories, A303-118A) were performed as 13 
described before (Villegas et al, 2019) using Dynabeads. 14 
Chromatin immunoprecipitation (ChIP) 15 
For ChIP of endogenous proteins or histone modifications, 8 x 106 cells per IP were fixed for 10min with 16 
1.1% formaldehyde in fixing solution (0.1M NaCl, 1mM EDTA, 0.5mM EGTA, and 50mM HEPES pH 17 
7.5) at RT on a rotating wheel, and neutralized with glycine to a final concentration of 0.125M for 5min 18 
at RT. Cells were washed three times with ice cold PBS by spinning at 1600g for 5min at 4°C, incubated 19 
for 10min at 4°C on a rotating wheel with 1ml lysis buffer 1 (50mM HEPES pH 7.5, 140mM NaCl, 1mM 20 
EDTA, 10% glycerol, 0.5% NP-40, and 0.25% TritonX), pelleted, and incubated for a further 10min at 21 
4°C in 1ml lysis buffer 2 (10mM Tris pH 8.0, 200mM NaCl, 1mM EDTA, and 0.5mM EGTA). Nuclei were 22 
pelleted, resuspended in 140µl shearing buffer (50mM Tris pH 8.0, 10mM EDTA, and 1% SDS), and 23 
sonicated in Diagenode 15ml Falcon tubes for 25 cycles (30 seconds ON, 30 seconds OFF) in ice-cold 24 
water using a Bioruptor Plus (Diagenode). 10% of sonicated DNA was kept as input sample. Lysates 25 
were further pelleted at 14000g for 10min at 4°C and the supernatant diluted 1:10 with ChIP dilution 26 
buffer (50mM Tris pH 8.0, 167mM NaCl, 1.1% Tx-100, and 0.11% Na-Deoxycholate). Lysates were 27 
precleared over 10µl Dynabeads for 2h and incubated overnight at 4°C on a rotating wheel with the 28 
following antibodies: 2µg H3K27ac (Active Motif, 39135), 2µg H3K9me2 (Abcam, ab1220), 2µg Zic2 29 
(Abcam, ab150404), or 2µg Zfp281 (Bethyl Laboratories, A303-118A). The next day, 10µl Dynabeads 30 
were added and incubated with lysates for 1h at 4°C on a rotating wheel. Beads were washed with 1ml 31 
of the following buffers for 5min each at 4°C: twice with wash buffer 1 (50mM Tris pH 8.0, 0.1% SDS, 32 
0.1% Na-Deoxycholate, 1% TritonX, 150mM NaCl, 1mM EDTA, and 0.5mM EGTA), once with wash 33 
buffer 2 (50mM Tris pH 8.0, 0.1% SDS, 0.1% Na-Deoxycholate, 1% TritonX, 500mM NaCl, 1mM EDTA, 34 
and 0.5mM EGTA), once with wash buffer 3 (50mM Tris pH 8.0, 250mM LiCl, 0.5% Na-Deoxycholate, 35 
0.5% NP40, 1mM EDTA, and 0.5mM EGTA), and twice with wash buffer 4 (50mM Tris pH 8.0, 10mM 36 
EDTA, and 5mM EGTA). Finally, beads were eluted twice with 100µl elution buffer (0.1M NaHCO3, and 37 
1% SDS) for 15min at RT in a shaker at maximum speed, and combined supernatants de-crosslinked 38 
overnight by supplementation to 200mM NaCl and continuous shaking at maximum speed at 65°C. The 39 
 37 
same procedure was followed for input samples by adjusting the total volume of elution buffer to 200µl 1 
and 200mM NaCl. The next day, DNA was purified using MinElute PCR Purification Kit (QIAGEN). 2 
Bio-ChIP for Flag-Avi tagged Ehmt1 was performed as described before (Ostapcuk et al, 2018) with 3 
minor modifications. Briefly, 8 x 106 cells per IP were fixed for 8min with 1% formaldehyde in PBS at 4 
RT on a rotating wheel, and neutralized with adjusting glycine to a final concentration of 0.125M and 5 
incubation for 1min at RT and for 5min on ice. Cells were washed three times with ice cold PBS and 6 
pelleted at 1000g for 5min at 4°C. Cells were lysed in lysis buffers 1 and 2 as described above. Nuclei 7 
were washed once in 5ml NUC buffer (15mM HEPES pH 7.5, 60mM KCl, 15mM NaCl, and 0.32mM 8 
sucrose) and resuspended in 1ml NUC Buffer supplemented with Complete Mini protease inhibitors, 9 
3.3µl 1M CaCl2, and 2-3µl Micrococcal Nuclease (Cell Signaling, 10011S). Enzymatic activity was 10 
induced for 15min at 37°C and shaking at 1000rpm, and stopped by addition of 50µl of STOP solution 11 
(250mM EDTA, and 500mM EGTA) and 110µl of 10x ChIP buffer (167mM Tris pH 8.0, 1.67M NaCl, 12 
12mM EDTA, 10% TritonX, and 0.1% SDS) with a further incubation for 5min on ice. Nuclei were gently 13 
disrupted by sonication in Diagenode 15ml Falcon tubes for 8 cycles (5 seconds ON, 5 seconds OFF) 14 
in ice cold water using a Bioruptor Plus. Lysates were centrifuged at 14000g for 5min at 4°C, 5% of the 15 
supernatant was kept as input sample, and the remaining supernatant precleared for 2h over 10µl 16 
Dynabeads at 4°C on a rotating wheel. Chromatin was incubated for 1h with M-280 Streptavidin coupled 17 
Dynabeads (Invitrogen) at 4°C on a rotating wheel, and washed with 1ml of the following buffers for 18 
5min each at 4°C: twice with TE buffer (10mM Tris pH 8.0, and 1mM EDTA) supplemented with 2% 19 
SDS, once with high salt buffer (50mM HEPES pH 7.5, 500mM NaCl, 1mM EDTA, 1% TritonX, and 20 
0.1% Na-Deoxycholate), once with wash buffer 3 (see above) and twice with TE buffer. Beads were 21 
eluted in 60µl elution buffer (see above) supplemented with 2µl RNaseA (10mg/ml stock) and incubated 22 
for 30min at 37°C while mixing. After supplementation to 10mM EDTA, 10mM Tris pH 8.0 and 2μl 23 
ProteinaseK (10mg/ml, Promega), the beads suspension was further incubated for 3h at 55°C and 24 
overnight at 65°C while shaking. The same procedure was followed for input samples, including 25 
RNaseA and ProteinaseK digestion. DNA was purified using AMPure XP beads (Beckman Coulter). 26 
Sequencing libraries 27 
RNA from ESCs grown in 2i and 16h and 32h after 2i withdrawal was isolated using RNAeasy kit 28 
(Qiagen). For Zfp281 KO and corresponding WT cells, total RNA was subjected to ribosomal RNA 29 
depletion using Ribozero removal kit (Illumina) followed by library construction using ScriptSeq V2 30 
library preparation kit (Illumina). For Ehmt1, Zic2, Ehmt1/Zic2 KO and corresponding WT cells, RNA-31 
seq libraries were prepared using TruSeq mRNA Library preparation kit (Illumina).  ChIP-seq libraries 32 
were prepared using NEBNext Ultra kit (New England BioLabs) following the manufacturer’s 33 
recommendations. Sequencing was performed on an Illumina HiSeq2500 machine (50bp single-end 34 
reads).  35 
Quantification and statistical analysis 36 
Screen analysis 37 
 38 
For the EpiSC reprogramming screen Z scores were calculated for each plate, excluding the two outer 1 
most columns and rows (Table EV1). Screen replicates are presented in Figure EV1B. Average Z 2 
scores >2 were considered as screen hits, identifying 146 genes (Figure 1B). We quantified their role 3 
in exit from the ESC state by extracting primary data for these 146 genes from two previous ESC 4 
differentiation studies (Betschinger et al, 2013; Li et al, 2018), and computing Z scores on this subset 5 
(Table EV1). 67 and 129 of the 146 genes were mapped on results from (Betschinger et al, 2013) and 6 
(Li et al, 2018), respectively, resulting in mapping of 130 genes in total. Average Z scores from both 7 
ESC differentiation screens are presented in Figure 1C.  8 
Quantification of immunostaining 9 
Quantification of H3K9me2 was performed in CellProfiler3 (Broad Institute). Nuclei were identified using 10 
Hoechst33342 staining and average H3K9me2 and DNA fluorescence intensity per nucleus 11 
determined: WT2i (453 cells), Zfp2812i (574 cells), WT32h (465 cells), Zfp28132h (792 cells). 12 
For quantification of d3 and d4 spheroids from two biological replicates, images were stitched to 13 
generate a single image per channel and per well, and used for object segmentation with Matlab 14 
(MathWorks). Segmented object outlines were exported and used for feature extraction with software 15 
package CellProfiler3. Extracted features (84 features) describing object area, shape and intensity were 16 
normalized within corresponding assay plates using Z score transformation and unified into a cross-17 
comparable dataset. Normalized features were used to extract 10 principal components (PC), which 18 
were further used for unsupervised clustering with the software package PhenoGraph (Levine et al, 19 
2015). Unsupervised clustering returned 13 clusters, objects belonging to the 2 sparsest clusters were 20 
discarded as outliers based on extreme variance in measured features in the respective classes. To 21 
describe radial distribution of F-actin signal intensity, segmented objects were divided into 20 concentric 22 
regions of same width. Distribution of F-actin staining intensity was described as mean fraction of 23 
intensity per region (MeanFrac) whereby the total intensity in the given region was normalized to the 24 
fraction of object area corresponding to the region. Mean fractions of intensity per region were not Z 25 
scored as these values were normalized per object ad initio. Visualization in Figure EV5G shows the 26 
mean of F-actin signal in a given concentric ring of all d4 spheroids per genotype and medium condition: 27 
WT2i (559 spheroids), Ehmt12i (349 spheroids), Zic22i (292 spheroids), Ehmt1/Zic22i (164 spheroids), 28 
Zfp2812i (324 spheroids), WT96h (437 spheroids), Ehmt196h (228 spheroids), Zic296h (202 spheroids), 29 
Ehmt1/Zic296h (233 spheroids), Zfp28196h (547 spheroids). Heatmap was generated using aheatmap 30 
function from the Bioconductor package NMF (Gaujoux & Seoighe, 2010) (package version 0.21.0). 31 
Protein identification and quantification 32 
Relative quantification of mass-spec data from three biological replicates (Table EV3) was performed 33 
with MaxQuant (version 1.5.3.8) using Andromeda as search engine and label free quantification as 34 
described (Villegas et al, 2019). Briefly, the mouse subset of the UniProt version 2015_01 combined 35 
with the contaminant DB from MaxQuant was searched and the protein and peptide FDR were set to 36 
0.01. For Figure 4A, B, proteins were considered which passed an interaction threshold of an at least 37 
twofold enrichment in IPs from WT2i or WT40h lysates compared to matched Zfp281 KO lysates with a 38 
significant p-value<0.1, and were quantifiable with at least two unique razor peptides. 39 
 39 
RNA-seq and Gro-seq analysis 1 
RNA-seq reads from wildtype and mutant cells in 2i, and 16h and 32h after 2i withdrawal were aligned 2 
to the mouse GRCm38/mm10 genome using qAlign from the Bioconductor package QuasR (Gaidatzis 3 
et al, 2015)  (package version 1.22.0) with default parameters except for splicedAlignment=TRUE. 4 
Published RNA-seq from ESCs cultured in 2i/Lif and EpiLC (Buecker et al, 2014) were 36bp reads, and 5 
therefore no spliced alignment could be performed. RNA-seq from ESCs cultured in 2i/Lif and EpiSCs 6 
(Factor et al, 2014; Bao et al, 2018), and global run-on sequencing (GRO-seq) data from 2i/Lif cultured 7 
ESCs (Dorighi et al, 2017) were 100bp and 50bp paired-end reads, respectively, and therefore 8 
paired=”fr” was used. For in vivo embryo data (Boroviak et al, 2015), pre-existing alignments to mouse 9 
GRCm38/mm10 genome were downloaded from ArrayExpress (E-MTAB-2958) and used. Alignments 10 
were quantified for known UCSC genes obtained from the TxDb.Mmusculus.UCSC.mm10.knownGene 11 
package (package version 3.4.4) using qCount from the Bioconductor package QuasR with default 12 
parameters (Table EV2). 13 
Only transcripts with at least 3 counts per million in at least two biological samples from this study were 14 
considered as expressed genes (total: 13,096 genes). For identification of significantly deregulated 15 
genes, edgeR (Robinson & Oshlack, 2010) (package version 3.24.0) was used and detected genes 16 
were fitted to two generalized linear models: 17 
(a) ~ time + genotype + time:genotype: This model uses WT2i, WT16h, WT32h, Zfp2812i, 18 
Zfp28116h and Zfp28132h expression datasets. Genes with a significant time coefficient are 19 
genes that change either between WT2i and WT16h or WT2i and WT32h cells, genes with a 20 
significant genotype coefficient are differentially expressed between Zfp2812i and WT2i 21 
cells, and genes with a significant interaction term time:genotype are deregulated in Zfp281 22 
KO cells specifically during 16h or 32h differentiation. 23 
(b) ~ genotype: This model identifies genes that differ between Ehmt12i and WT2i cells.  24 
Raw P values were corrected for multiple testing by calculating false discovery rates (FDR). Significant 25 
genes were identified as genes with an absolute log2 fold-change greater than 1.0 and an FDR of less 26 
than 0.01. 27 
For visualization of RNA-seq data, except principal component analysis (PCA) in Figure 6A and 6B and 28 
heatmap of selected markers in Figure EV6A, log2 fold-change values were used that were obtained 29 
from edgeR by fitting the indicated datasets to the following models: 30 
(c) ~ time (EpiLCs or EpiSCs): EpiLCs (Buecker et al, 2014) or EpiSCs (Factor et al, 2014) 31 
compared to WT2i/Lif (Buecker et al, 2014) and EpiSC compared to WT2i/Lif (Bao et al, 2018) 32 
(used for Figure 3A, B). 33 
(d) ~ genotime: Zfp28116h or Zfp28132h compared to WT2i (used for Figure 3A, B and EV3A), 34 
where genotime is the combination of genotype and time. 35 
(e) ~ genotype (cell state-specific): KO cells in 2i compared to WT2i, or KO cells 16h or 32h 36 
after 2i withdrawal compared to WT16h or WT32h, respectively (used for Figure 3C and 6C, 37 
D and EV6B-E).  38 
 40 
For heatmap visualization in Figure 3A only significantly deregulated genes in at least one condition 1 
were considered (model (a): time, genotype or time:genotype; total: 2,495 genes) and the following log2 2 
contrast were used for clustering: WT16h-WT2i, WT32h-WT2i, Zfp2812i-WT2i, Zfp28116h-WT2i, Zfp28132h- 3 
WT2i, Zfp28116h-WT16h and Zfp28132h-WT32h. For heatmap visualization in Figure EV6A, RNA-seq read 4 
counts were normalized (divided by the total number of aligned reads (library size), multiplied with 5 
minimal library size, and added with a pseudocount of 8) and log2 transformed, and the mean of 6 
biological replicates was plotted. For visualization in Figure EV6B, significantly deregulated genes in 7 
Ehmt12i (model (b): genotype) but not Zfp2812i (model (a): genotype) are highlighted. In Figure 3B, dots 8 
represent the median and shades the lower and upper quartile of indicated samples. Boxplots were 9 
generated using the boxplot function in R with default parameters except outline=FALSE. Correlation 10 
plots (Figure EV6C, D) were generated using corrplot function from the Bioconductor package corrplot 11 
(https://github.com/taiyun/corrplot) (package version 0.84). Heatmaps (Figure 3A, EV3A and EV6A) 12 
were generated using aheatmap function from the Bioconductor package NMF. For PCA represented 13 
in Figure 6A, normalized (see above) and log2 transformed read counts were centered by subtracting 14 
the average of WT ESCs within each of the following four RNA-seq data sets: 1) Zfp281 KO and 15 
corresponding WT samples from this study; 2) Ehmt1, Zic2, Ehmt1/Zic2 KO and corresponding WT 16 
samples from this study; 3) WT2i/Lif cells and EpiLCs (Buecker et al, 2014); and 4) WT2i/Lif cells and 17 
EpiSCs (Bao et al, 2018). For PCA represented in Figure 6B, normalized (see above) and log2 18 
transformed read counts were centered by subtracting the average over all samples within each of the 19 
following three RNA-seq data sets: 1) Zfp281 KO and corresponding WT samples from this study; 2) 20 
Ehmt1, Zic2, Ehmt1/Zic2 KO and corresponding WT samples from this study; 3) WT2i/Lif cells and 21 
embryo samples (Boroviak et al, 2015). Centered read counts for each PCA are provided in Table EV2 22 
and the detailed R code is provided in Appendix File 1. PCA was performed using the prcomp function 23 
in R. Analyses of enriched gene sets (Figure EV1C, EV3B and EV6B) were performed using DAVID 24 
(Huang et al, 2009) (version 6.8) for GO terms of biological processes. 25 
The linear model to estimate synergistic transcriptional effects of Ehmt1 and Zic2 (Figure EV6E) was 26 
fitted using lm function in R: 27 
 ∆Ehmt1/Zic2i ~ βE∆Ehmt1i + βZ∆Zic2i + βint∆Ehmt1:Zic2i 28 
 ∆: transcriptional difference (KO – WT) of gene i 29 
 β: regression coefficient:  30 
      E: Ehmt1 31 
      Z: Zic2 32 
      int: non-additive interaction 33 
ChIP-seq and DHS-seq analysis 34 
ChIP-seq data from this study, published datasets (Buecker et al, 2014; Huang et al, 2017; Ishiuchi et 35 
al, 2019) and DNAseI hypersensitive site sequencing (DHS-seq) (Encode; accession number: 36 
ENCSR000CMW) reads were aligned to mouse GRCm38/mm10 genome using qAlign from the 37 
Bioconductor package QuasR with default parameters. Published H3K4me3, H3K27me3 and 38 
H3K9me2 ChIP-seq data (Kurimoto et al, 2015) were aligned using Bowtie (Langmead et al, 2009) 39 
 41 
(version 4.4.7) with parameter -C in colorspace. Alignments were sorted and indexed using SAMtools 1 
(package version 1.2), and all ChIP-seq data were quantified with qCount from the Bioconductor 2 
package QuasR. Read counts were normalized (divided by the total number of aligned reads (library 3 
size), multiplied with minimal library size and added with a pseudocount of 8) and log2 transformed. For 4 
DHS-seq, reads per million (RPM) were calculated by dividing the total number of aligned reads, 5 
multiplying with one million, adding a pseudocount of 8 and log2 transforming the data.  6 
We observed a non-linear relationship in Zfp281 ChIP-seq data when comparing read counts in Zfp281 7 
peaks between ChIP-seq replicates in WT2i, and therefore performed loess regression using 8 
normalizeBetweenArrays function of the Bioconductor package limma (Ritchie et al, 2015) (package 9 
version 3.38.2) with method=cyclingloess. 10 
In Ehmt1 ChIP-seq data we detected a variable dependency of read counts in genomic tiles on the tile’s 11 
GC composition (GC bias) which was most pronounced in input samples. In order to reduce this bias, 12 
we used a loess-based normalization method: First, reads were counted in each sample in 10kb 13 
windows (either genome-tiling windows or windows centered on Zfp281 peaks and corresponding 14 
control windows, see below). The counts were then scaled (divided by the total number of aligned reads 15 
(library size)), multiplied with minimal library size, added with a pseudocount of 8, and log2 transformed. 16 
A loess curve was fit to the log2-transformed counts as a function of the fraction of G+C bases in the 17 
window using the R function loess with span = 0.3. This fit robustly captures the global signal 18 
dependency on the underlying GC composition. GC-corrected log2 read counts were then obtained by 19 
subtracting the values predicted by the loess fit from the observed log2 read counts (residuals of the 20 
fit).    21 
Zfp281 peaks were called on Zfp281 ChIP-seq reads in WT2i and WT32h cells using Macs2 (Zhang et 22 
al, 2008) (version 2.1.1.20160309) with default parameters. Peaks that were at least 2-fold enriched (IP 23 
over respective inputs) in at least one of the four Zfp281 ChIP samples were considered (total: 23,756 24 
peaks) (Table EV2). For comparison of Zfp281 ChIP samples from this study to ChIP in EpiSCs (Huang 25 
et al, 2017) and TSCs (Ishiuchi et al, 2019), peaks were called on Zfp281 ChIP-seq reads in WT2i, 26 
WT32h, EpiSCs and TSCs. Peaks that were at least 2-fold enriched (IP over respective inputs) in at least 27 
one of the four Zfp281 ChIP samples from this study, in the one Zfp281 ChIP sample in EpiSCs or in 28 
one of the two Zfp281 ChIP samples in TSCs were considered (total: 27,435 peaks) and used for 29 
plotting (Figure EV3E and F). Zic2 peaks were called on Zic2 ChIP-seq reads in WT2i, WT32h, Zfp2812i 30 
and Zfp28132h cells. To quantitatively compare Zfp281 and Zic2 binding, both peak sets were combined 31 
and overlapping peak regions were merged using the function reduce from Bioconductor package 32 
GenomicRanges (Lawrence et al, 2013) (package version 1.34.0). Fused peaks were classified into 33 
single- or co-bound as follows: Peaks that were enriched at least 2-fold (IP over respective inputs) in at 34 
least one of the four Zfp281 ChIP samples and in at least one of the eight Zic2 ChIP samples were 35 
considered as co-bound (total: 8,312 peaks), while if detected only in Zfp281 ChIP or only in Zic2 ChIP 36 
samples were considered  as Zfp281-only (total: 15,659 peaks) or Zic2-only (total: 20,183 peaks), 37 
respectively (Table EV2). Reads of H3K27ac ChIP-seq datasets were counted in Zfp281, Zic2 or 38 
Zfp281/Zic2 co-bound peaks and normalized as described above. 39 
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Zfp281 or Zfp281/Zic2 co-bound peaks were assigned to genes by calculating the distances of peak 1 
midpoint to the nearest transcriptional start site (TSS) using a set of non-redundant TSSs with a single 2 
start site randomly selected for each gene. Zfp281 peaks were classified as proximal if the distance to 3 
the nearest TSS was less than 2000bp (7,697 peaks) and as distal otherwise (16,059 peaks) (Figure 4 
EV3G). H3K27ac reads in WT2i and WT32h cells, and H3K4me1 (Buecker et al, 2014) and H3K4me3 5 
(Kurimoto et al, 2015)  reads in WT2i/Lif and EpiLCs were counted in Zfp281 peak regions and normalized 6 
as described above. Proximal Zfp281 binding sites with at least 1.5-fold enrichment of H3K27ac over 7 
respective inputs in either WT2i or WT32h cells and with at least 2-fold enrichment of H3K4me3 over 8 
respective inputs in either WT2i/Lif cells or EpiLCs were considered as associated with active promoters 9 
(54% of proximal peaks, total: 4,128). Distal Zfp281 binding sites with at least 1.5-fold enrichment of 10 
H3K4me1 over respective inputs in either WT2i/Lif cells or EpiLCs were considered as putative 11 
enhancers (62% of distal peaks, total: 9,990), of which sites additionally enriched at least 1.5-fold over 12 
respective inputs in H3K27ac in either WT2i or WT32h cells were classified as active enhancers (38% of 13 
putative enhancers, total: 3,818). For quantification at target sites differentially bound by Zfp281 during 14 
differentiation (Figure 3F, 7C, D), the 1000 binding sites with strongest increase (Zfp281 UP) and 15 
decrease (Zfp281 DOWN) in Zfp281 ChIP signal in WT32h compared to WT2i were considered. 16 
Due to the broad chromatin distribution of Ehmt1 and H3K9me2, ChIP-seq reads were first quantified 17 
in genome-tiling windows of 10kb which were generated using tileGenome function from Bioconductor 18 
package GenomicRanges with tilewidth=10000 and cut.last.tile.in.chrom=TRUE. In Figure EV7C, all 19 
10kb genome-tiling windows were separated in 5 bins with equal number of tiles but increasing Ehmt1 20 
ChIP log2 enrichment over respective input in WT2i cells. To quantify Ehmt1 and H3K9me2 enrichment 21 
at Zfp281 binding sites, Zfp281 peak regions were extended to 10kb centered on the peak midpoint 22 
using the function resize from the Bioconductor package GenomicRanges. As a control set, DHS-seq 23 
peaks (peak annotation downloaded from ENCODE; accession number: ENCSR000CMW) were 24 
extended to 10kb centered on the peak midpoint and only regions non-overlapping with 10kb extended 25 
Zfp281 peaks were considered. The final set of control regions was obtained by randomly sampling one 26 
DHS 10kb peak per Zfp281 10kb peak, such that the distributions of DHS-seq signal (log2 RPM) and 27 
GC-content between Zfp281 10kb extended peaks and the selected control regions matched closely.  28 
Boxplots were generated using the boxplot function in R with default parameters except outline=FALSE. 29 
Genomic profiles for heatmaps centered on the Zfp281 peak midpoint (Figure EV3G) were generated 30 
with qProfile from the Bioconductor package QuasR, and visualized using ComplexHeatmap (package 31 
version 1.20.0) (Gu et al, 2016). Except for Zfp281 ChIP-seq and GRO-seq (Dorighi et al, 2017), the 32 
averages of two replicates are shown. 33 
Details for quantification and statistical analysis in Figures 34 
Details of experiments can be found in the figure legends, including number of biological or technical 35 
replicates and the statistical test used. All data quantification is represented as the mean and standard 36 
deviation (SD). 37 
Data availability 38 
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Next-generation sequencing data reported in this study have been deposited at the Gene Expression 1 
Omnibus with accession number GSE131017. Reviewers can get access to the data by searching for 2 
the above GSE identifier and then using the token kbsncwsufzknpgz.  3 
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EXTENDED VIEW FIGURES 1 
 2 
Figure EV1: Enhanced reprogramming of EpiSCs in the absence of Zfp281. 3 
(A) Self-renewal of O4GIPGY118F reprogramming intermediates after 2 or 4d in 2i in the presence or 4 
absence of Gcsf. Average and SD of 2 experiments performed in duplicates. 5 
(B) Scatter plot of Z scores between screen replicates. Negative controls (no esiRNA and non-targeting 6 
Luc esiRNA) are marked in yellow and green, respectively, and positive controls (Stat3 esiRNA) in blue. 7 
Pearson’s correlation coefficient (R). 8 
(C) Top 5 GO terms enriched in screen hits with Z scores > 2 (top) and < -2 (bottom). 9 
(D) Deconvolution of siRNA pools: Epi-iPSC colonies derived from 796.4 EpiSCs transfected with 10 
indicated siRNAs (individual siRNAs or pools), stimulated for 4d with Gcsf and 2i, and selected with 11 
Puromycin. Average and SD of 3 experiments performed in duplicates. 12 
(E) Induction of naïve (top) and repression of primed (bottom) pluripotency markers in Epi-iPSCs 13 
derived from Zfp281-depleted and Gcsf-stimulated O4GIPGY118F and 796.4 EpiSCs. mRNA fold changes 14 
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relative to ESCs (top) and EpiSCs (bottom) are shown on a log(10)-scaled axis. Average and SD of 2 1 
technical replicates. Not detected (n.d.). 2 
(F) Epi-iPSC colonies derived from O4GIPempty and O4GiPGY118F EpiSCs transfected with indicated 3 
siRNAs, incubated for 4d in 2i in the presence or absence of Gcsf, and selected with Puromycin. 4 
Average and SD of 2 technical replicates.  5 
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Figure EV2: Characterization of Zfp281 and Tet enzymes in ESC differentiation. 1 
(A, B) Sequence of genome-edited Zfp281 locus (A) and absence of protein (B) in KO cells. E denotes 2 
E14 parental cell line origin. 3 
(C, E, F) Self-renewal in RGd2 cells (C) and of indicated genotypes (E, F) after 3d (E) or indicated 4 
timepoints (C, F) of 2i withdrawal. Average and SD of 2 experiments performed in duplicates. 5 
(D, L) Representative flow cytometry profiles of RGd2 ESCs of specified genotypes, at indicated 6 
timepoints and in indicated conditions. Numbers are average and SD of GFPhigh cells in 2 experiments. 7 
(G) Flow cytometry profiles (left panel) of longterm-differentiated Zfp281 KO.2 cells in N2B27 and 8 
indicating GFP sorting gates (left), and of unsorted or sorted GFPlow,sort and GFPhigh,sort cells after an 9 
additional 2-3 days of culture in N2B27 and indicating gates used for quantification of GFP distribution 10 
(right). Please note that profiles shown on the right were recorded on a different instrument than the 11 
profile presented on the left. Quantification of GFP distribution (right panel) in N2B27 cultures derived 12 
from indicated sorted cells of specified genotypes. Average and SD of 2 experiments.  13 
(H) Zfp281 transcription relative to untreated WT2i cells in Zfp281-inducible ESC clones after 48h in 2i 14 
and in the presence or absence of Dox. Average and SD of 2 technical replicates. 15 
(I) Self-renewal of sorted GFPhigh,sort and GFPlow,sort populations of indicated genotypes after exposure 16 
to Dox (green) or control conditions (black) for 48h. Green circles on x axis mark Dox-treated non-self-17 
renewing samples. Average and SD of 2 technical replicates. 18 
(J, K) Sequence of genome-edited Tet1 and Tet2 loci (J) and absence of proteins (K) in KO cells. 19 
(M) Western blot showing Zfp281 protein levels during ESC progression. 20 
(N,O) Nanog (N,O) and Zfp281 (O) mRNA levels relative to WT2i cells in ESCs of specified genotypes 21 
(N) and in indicated EpiSCs 24h after transfection of neg and Zfp281 siRNAs (O). Average and SD of 22 
5 (N) and 2 (O) experiments performed in duplicates. 23 
(P) Resistance to differentiation in O4GIP ESCs transfected with indicated siRNA combinations after 24 
3d of 2i withdrawal relative to untransfected cells. Average and SD of 2 experiments performed in 25 
duplicates.  26 
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Figure EV3: Genomics of Zfp281. 1 
(A) mRNA log2FC relative to WT2i cells of selected core, naïve and primed pluripotency markers in 2 
differentiating WT and Zfp281 KO cells at indicated timepoints. 3 
(B) Top 5 enriched GO terms in clusters 1-6. 4 
(C) Sequence logo from the de novo identified binding motif in 82.4% of 23756 Zfp281 peaks. 5 
(D) Scatter plot comparing log2 Zfp281 peak ChIP enrichment over matched inputs between replicates 6 
in WT2i (top) and WT32h (bottom) cells. 7 
(E, F) Scatter plot comparing log2 Zfp281 ChIP enrichment over matched inputs in WT32h cells and 8 
EpiSCs (Huang et al, 2017) (E) and TSCs (Ishiuchi et al, 2019) (F). Peaks were assigned to closest 9 
transcriptional start sites (TSSs) and colored according to association with gene clusters 1-6. 10 
(G) Heatmap of Zfp281, H3K27ac, histone H3 K4 tri-methylation (H3K4me3), H3K4 mono-methylation 11 
(H3K4me1) and histone H3K27 tri-methylation (H3K27me3) ChIPseq, DNAse-hypersensitive sites 12 
(DHS) and global run-on sequencing (GROseq) read densities across all proximal (+/- 2kb of TSS) 13 
Zfp281 (top) and distal Zfp281 (bottom) peaks. Each row represents a 10kb window centered on the 14 
peak mid of Zfp281. Rows are sorted for H3K27ac ChIP read densities in ESCs. Reads per million 15 
(RPM).  16 
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Figure EV4: Characterization of Ehmt1 and Zic2 downstream of Zfp281. 2 
(A, D, G) Representative flow cytometry profiles of Zfp281-inducible RGd2 ESCs transfected with 3 
indicated siRNAs (A), of RGd2 ESCs with conditional Ehmt1 and Zic2 expression (D), and of Dnmt3a/3b 4 
compound KO RGd2 ESCs with conditional Zfp281 expression (G) after 32h in 2i and in the presence 5 
(green) or absence (black) of Dox. Significance (G) was determined using a Wilcoxon Mann-Whitney 6 
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rank sum test compared to WTind. Zfp281.1 Dox-treated cells. not significant (n.s.)>=0.05. Numbers are the 1 
average and SD of GFPlow cells in 2 (D) and 4 (G) experiments. 2 
(B, C, F) FC Ehmt1 (B), Zic2 (C) and Zfp281 (F) transcription relative to untreated WT2i cells in indicated 3 
ESC clones after 32h in 2i in the presence or absence of Dox. Average and SD of 2 technical replicates. 4 
(E) Sequences of genome-edited Dnmt3a and Dnmt3b loci in WTind. Zfp281.1 cells. 5 
(H) Whole cell lysate Zfp281 IPs in WT and Zfp281 KO cells in 2i or 40h after 2i withdrawal, and probed 6 
for indicated proteins. Input (left) and Zfp281 IP (right). (*) Ig heavy chain.  7 
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Figure EV5: Characterization of Ehmt1, Zic2 and Ehmt1/Zic2 KO cells. 1 
(A, B) Sequence of genome-edited Ehmt1 and Zic2 loci (A) and absence of proteins (B) in KO cells. 2 
(C-E) Cell morphologies (C), growth curves (D) and cell cycle analyses using propidium iodide staining 3 
(E) of indicated genotypes in 2i. Average and SD of 3 experiments (D, E). 4 
(F, I) Representative flow cytometry profiles of indicated genotypes in 2i, and after 32h and 72h of 2i 5 
withdrawal (F), and in 2i and 32h after 2i withdrawal (I). Numbers (F) are the average and SD of GFPhigh 6 
cells in 2 experiments. 7 
(G) Quantification and hierarchical clustering of normalized F-actin intensity in 20 concentric rings (from 8 
center to circumference) in spheroids derived from ESCs with indicated genotypes in 2i or N2B27 for 9 
4d. Intensity is color-coded and illustrates central F-actin accumulation and, hence, polarization of WT 10 
and Zic2 KO cells during differentiation.  11 
(H) Representative immunofluorescence staining of WT or Ehmt1 KO ESCs expressing the indicated 12 
transgenes. Top: H3K9me2 and DAPI. Bottom: Ehmt1. Co-localization of H3K9me2 with DAPI-rich 13 
speckles in Ehmt12i cells expressing no transgene, the ∆NHHC, or NH-LE alleles is indicated by 14 
arrowheads. Please note absence of nuclear Ehmt1 staining in Ehmt12i cells and restoration by Ehmt1 15 
transgenes. Scale bar is 10µm.  16 
(J) Deconvolution of siRNA pools: Epi-iPSC colonies derived from 796.4 EpiSCs transfected with 17 
indicated siRNAs (individual siRNAs or pools), stimulated for 4d with Gcsf and 2i, and selected with 18 
Puromycin. Average and SD of 3 experiments performed in duplicates.  19 
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Figure EV6: Ehmt1 and Zic2 transcriptomics. 2 
(A) log2 normalized read counts of selected core, naïve and primed pluripotency markers in ESCs of 3 
indicated genotypes. 4 
(B) Scatter plot of mRNA log2FC in Zfp2812i and Ehmt12i cells (left). Top 5 GO terms enriched in genes 5 
upregulated (red) and downregulated (blue) specifically in Ehmt12i cells (right). 6 
(C, D) Pairwise Pearson correlation coefficients of mRNA changes between indicated differentiated 7 
cells considering all detected transcripts (C) or gene cluster 1-6 transcripts (D). 8 
(E) Estimated regression coefficients for the contribution of Ehmt1 (Ehmt1), Zic2 (Zic2) and their 9 
interaction (Ehmt1:Zic2) to cell state-specific gene expression changes in Ehmt1/Zic2 compound KO 10 
cells.  11 
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Figure EV7: DNA binding of Ehmt1 and Zic2. 2 
(A) Western blot confirming Ehmt1 biotinylation (probed with Streptavidin (Strep)) in ESCs of indicated 3 
genotypes expressing the BirA ligase.  4 
(B) ESC self-renewal of indicated genotypes after 3d of 2i withdrawal. Average and SD of 3 experiments 5 
performed in duplicates. 6 
(C) Log2 Ehmt1 and H3K9me2 ChIP enrichment in ESCs over matched inputs at five classes of 10kb 7 
genome-wide windows binned by increasing Ehmt1 chromatin association. 8 
(D, E) Ehmt1 (D, E) and H3K9me2 (E) ChIP log2FC between indicated cell states and genotypes at 9 
Zfp281 peaks (purple) or matching and non-overlapping DHS control peaks (grey) extended to 10kb 10 
windows. 11 
(F) Representative immunofluorescence staining of H3K9me2 (left) and quantification relative to DNA 12 
(right) in indicated genotypes and conditions. Scale bar is 10µm.  13 
(G) Density plot showing distance of Zfp281-only (pink), Zic2-only (blue) and Zfp281/Zic2 co-bound 14 
peaks (yellow) to nearest TSS. 15 
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(H) Zfp281 (left), Zic2 (middle) and H3K27ac (right) log2 ChIP enrichment over matched inputs in ESCs 1 
at Zfp281-only (pink), Zic2-only (blue) and Zfp281/Zic2 co-bound (yellow) peaks. 2 
(I) Cell state-specific Zic2 ChIP log2FC between indicated genotypes and cell states at Zfp281-only 3 
(pink), Zic2-only (blue) and Zfp281/Zic2 co-bound (yellow) peaks. 4 
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